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I. INTRODUCTION 
Geriatric health care has witnessed the emergence of a 
new para-health professional, the informal caregiver. A 
caregiver is one "who attempts to meet the physiological and 
psychosocial needs of a frail and dependent elder".1 The 
role, or expected behaviors, of the informal caregiver has 
been described as "a nurse" or "quas iprof ess ional" . 3 
These labels are appropriate since they are expected to 
provide for the patient's general comfort, intervene on 
their behalf, perform complicated medical treatments at 
home, and administer and monitor medications. 
Research on caregivers has typically focused on the 
family. The elderly spouse caregiver, as the unit of 
analysis, has received little attention in the literature. 
The elderly spouse is in a unique position because of 
his/her own limitations. The spouse's own aging process 
compounds the difficulty in caregiving responsibilities. 
Over 86% of the elderly have at least one chronic 
disease which requires the use of prescription medications."* 
Furthermore, 33% of all elderly experience adverse drug 
reactions which impair function, require hospitalization, or 
contribute to mortality. Since the elderly spouse caregiver 
and the patient frequently take multiple medications, 
carefully detailed, easily understood medication information 
is necessary. 
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To date there has been no research to identify the 
specific types and amounts of medication information the 
caregiver needs in order to safely and effectively manage 
the patient's medication regimen at home. Consequently, 
this study focused specifically on the importance of various 
types of drug information as assessed by elderly spouse 
caregivers. In addition, pharmacists were surveyed to 
determine their perceptions of the types of drug information 
required by elderly spouse caregivers. 
A review of the literature will be presented in two 
sections. The first will focus on the functional ability of 
the aged and trends of caregiving focusing on the elderly 
spouse caregiver. The second section will summarize 
pertinent medication literature as it relates to the 
research problem. 
II. LITERATURE REVIEW 
A. The Elderly and Their Caregivers 
1. Growing number of elderly 
The elderly are the fastest growing segment of the 
population. In 1981 there were 26 million people over the 
age of 65. This number is expected to increase to 35.1 
million over the next 20 years.55 In 20 years, the number of 
those 75 to 84 years of age will increase by 53%, and those 
over 85 years of age will grow by 64%. These segments of 
the population are growing at a faster rate than younger 
populations. 
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2. Decreasing functional ability with advancing age 
Although the majority of elders are relatively healthy, 
chronic disease and functional impairment becomes more 
prevalent with increasing age. 6 - 1 1 Approximately 12% of 
those aged 65 to 69 are functionally impaired. •• l 2 ! This 
increases to 80% for those over age 85. The National Council 
on Aging reports 25-50% of all elderly need help with 
routine activities of daily living.13 Ten percent of the 
elderly are confined to bed or homebound and are at least as 
functionally impaired as their peers in long-term care (LTC) 
facilities. 
In the United States, life expectancy at age 65 is 
approximately 17 years. "Active life expectancy" (ALE) is 
the number of years of functional well being. For the 
ambulatory 65 to 69 year old, total life expectancy is 16.5 
years but ALE decreases to 10 years. The proportion of 
dependent years increases with age. Therefore, those over 
85 years old tend to need assistance with approximately 60% 
of their remaining 7.3 years of life. 
3. Care responsibility for the elderly 
Two to three times as many frail and disabled elders 
live at home compared to peers in long-term care (LTC) 
facilities. The difference between the elderly residing at 
home and those in LTC facilities is not related to their 
health status or level of disability, but rather to the 
availability of the family as the caregiver . 1 - e s- 1 = 5 - 1 ^  
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Eighty to 90% of ill elders living at home depend on 
families for their care.® 
The number of frail and disabled elders needing in-home 
care will increase considerably in coming years. Results of 
the Informal Caregivers Survey established that 
approximately 2.2 million caregivers provided assistance to 
non-institutionalized elders in 1982.1B Health care 
professionals, social service personnel, government policy-
makers, and researchers have emphasized methods to maintain 
the frail and disabled elder at home.155 The growth of the 
elderly population, cost containment measures applied to 
Medicare and other medical coverage, and the desire for the 
elder to remain in the home have all contributed to the 
growing demand for informal caregivers .1» 1 = ' 1 6» 1S>' 3 5 0 
Research on the caregivers of disabled elders has 
established credible evidence of the physical, emotional, 
and financial strain inherent in this r o l e . 1 1 - 1 = ' 1 7 » t 9 ' 2 1 " 2 9 
The term "caregiver burden" is used to refer to problems 
experienced by family members caring for the impaired older 
adult.523 Caregivers report increased depression, poorer 
health, increased use of prescription medications, and a 
higher utilization of health care services compared to 
matched community controls.30'31 
In-home care required by the frail elder often becomes 
unmanageable. The ill elder's complicated care regimen 
often results in the exhaustion of the caregiver.32 Several 
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researchers have suggested that the primary reason for LTC 
placement is the exhaustion of the caregiver due to the 
demands of providing c a r e . 1 6 - 1 7 - 2 0 ' 3 3 Ironically, however, 
utilization of available formal home health care services by 
caregivers has been much lower than expected. The 
caregivers often have difficulty identifying formal home 
health care service needs.3"* Goodman speculates that the 
utilization is reduced as a result of increased isolation.^ 
In efforts to maintain dependent elders at home, home health 
care services for the patient as well as the caregiver 
requires further investigation. 
4. Elderly spouses as caregivers 
The importance of the spousal caregiver in the health 
care system has been documented. The spouse, as primary 
caregiver, has been identified as the "uppermost member in 
the hierarchy of the caregiving ladder".355 Christie-Seely 
described the spouse caregiver as the most influential 
"change agent" on the health care team.36 Health care 
professionals lack personal insights and unique knowledge 
that the spouse contributes. The spouse fulfills an 
essential role in interpreting the patient's symptoms and 
responses to medical therapy.Spouses can also have a 
positive influence on the patient's compliance and attitudes 
about health care. 3 7" 3 9 
Unfortunately, caregivers are expected to perform in 
this role with little education or support from health care 
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professionals. The spouse caregiver experiences uncertainty 
and helplessness and reports the need to gain a sense of 
control.26' "*0' "*x Bishop and colleagues indicated that 
caregivers of stroke patients were concerned about 
controlling symptoms and complying with prescribed regimens 
at home.21 Similarly, caregivers of chronic obstructive 
pulmonary disease (COPD) patients reported the following 
problems: symptom control, worry over the patient's health, 
and anxiety about recovery."*2 In a study of 19 caregivers, 
Peterson indicated that the psychological problems of 
caregiving increased when the caregiver carried the primary 
responsibility and the patient assumed a passive role.2& 
Elderly spouses, compared to other types of caregivers, 
are considered at highest risk for the detrimental effects 
of caregiving.31-"*3"-"*= They are often unable to maintain 
the emotional and physical demands of managing their frail 
and disabled mate because of their own aging processes and 
possible chronic illnesses.31'"*e'"*7r Deterioration of the 
caregiver's physical health often results from their efforts 
to maintain the dependent spouse at 
home , 2 3' 2 7 ' 3 1 ' "*3-"*=' "* e-Compounding these problems, the 
elderly spouse caregiver is less likely to relinquish 
his/her role and institutionalize the dependent spouse 
compared to daughters, sons, or other relatives providing 
care.33' "*= 
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The major challenge for health care professionals is 
providing spouse caregivers a sense of confidence through 
education. 8 3 0'The acquisition of new knowledge can be 
effective in reducing the caregiver's perceived burden.17 
In fact, Pearson-Scott reported that 93% of caregivers of 
patients with Alzheimer's disease found actively seeking 
information to be the most effective coping strategy.27 An 
increased ability to cope was also reported by caregivers 
given relevant information about the pathophysiology of the 
patient's illness, rationale for treatment, and potential 
treatment complications.32 The development of a checklist 
that records whether the caregiver has been informed about 
the spouse's medications has also been suggested.551 
B. Medication Literature 
1. Drug information needs of the patient 
Few studies have specifically examined the information 
which patients should know about their medications. Most 
physicians, pharmacists, and other health care professionals 
(HCPs) agree that patients should be educated about drug 
therapy and encouraged to participate in medical decisions. 
However, few HCPs agree on the specific types of information 
or the most effective method for providing drug education to 
the patient.=3 
Patients' views concerning drug information were 
evaluated in a pilot program for the development of Patient 
Package Inserts .5S"*'=s= Most patients wanted detailed 
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information beyond the simple dosing instructions. Over 75% 
of all patients expressed the desire to know overdose 
information, risks of under- and overusing medications, and 
all other possible risks. Therefore, patients generally 
want as much information as possible about their condition 
and its treatment. 
In contrast, health professionals often underestimate 
the type of drug information desired by patients. In a 
study by Ley, patients' reports of drug information needs 
generally differ from physicians' and pharmacists' 
evaluations.556 Whereas 80% of patients desired information 
about risks of noncompliance with the prescribed regimen, 
slightly less than 50% of the physicians thought patients 
would be interested in this type of information. In 
general, pharmacists also tended to underestimate the amount 
of information patients desired although to a lesser extent 
than the physicians. 
Professional organizations have published guidelines 
for providing patients with essential medication 
information. The American College of Physicians recommends 
patients be told the following: reasons the drug was 
prescribed; ways it should be taken; common side effects and 
how to deal with them; and warnings about serious problems 
that demand prompt cessation of the drug.837 The National 
Council on Patient Information and Education (NCPIE) 
recommends patients know: the name and what the drug is 
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supposed to do; how, when, and the duration of drug therapy; 
food, drink, and other medications to avoid; side effects 
and what to do about them; and what written information is 
available 
2. Drug use by the elderly 
The elderly account for 12% of the current population 
but consume 30% of all prescription medications. ss'® Between 
the ages of 65 to 69, 86.8% of the elderly use at least one 
prescription medication daily. Utilization increases to 
92.4% for those between the ages of 80 to 84 . 5 5 9 This age-
related increase in drug usage is probably due to the 
increase of chronic diseases with aging coupled with the 
fact that drug therapy is the most common form of treatment 
for the elderly. Of physician visits by the elderly, 75% 
are associated with the continuation or initiation of 
prescription medications.60 
Recently, there has been encouragement to reduce the 
number of medications which the elderly receive. Many drugs 
are either unnecessary or of doubtful value.61 To 
longitudinally assess drug utilization patterns, Hale ex-
amined the use of prescription medications in 2,834 
ambulatory elders over two time periods.62 In 1978, the 
average number of medications was 3.2 per person. This mean 
increased to 3.7 medications per person between 1983 to 
1985. Therefore, despite the recommendations to reduce the 
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elderly's prescription medications, a 15.6% increase in 
medication utilization was observed. 
As for over-the-counter medications (OTCs), estimates 
indicate 40% of the elderly use OTCs daily. Utilization 
rates for the elderly are seven times the rate by younger 
persons.63 The following reasons are cited for this higher 
utilization: 1) reduced mobility; 2) increased symptomatic 
complaints; and 3) increased self-treatment because of low 
or fixed incomes. Hale determined that the three categories 
of OTCs most frequently used by the elderly were analgesics, 
nutritional supplements, and laxatives.6,2 
3. Adverse drug reactions in the elderly 
The frequency and severity of adverse drug reactions in 
persons over age 65 are additional reasons for examining 
medication u t i 1 i z a t i o n . A d v e r s e drug reactions occur 
more often and are more severe in the elderly.61 • it 
has been estimated that 33% of the elderly will experience 
an adverse drug event. Compared to those patients 50 years 
of age and under, elderly between the ages of 60 and 70 and 
those over 80 years old have a two and three times greater 
risk of adverse drug reactions respectively. The risk of 
adverse drug reactions increases markedly as the number of 
medications and chronic diseases increase. 
Adverse drug reactions are the most common form of 
iatrogenic illness in the elderly.67 Lack of appropriate 
supervision of drugs used in the management of chronic 
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disease is a major problem.66 Serious medical complications 
and costly hospitalizations are precipitated by patients' 
failure to follow the prescribed regimen.3ES For example, 
10-28% of all geriatric admissions to hospitals are due to 
adverse drug reactions.61'71 
The inability of the elderly to take medications 
appropriately has also been reported to be a significant 
predictor of premature institutionalization.67'72 Of the 
patients in nursing homes, 24% are placed primarily because 
of their inability to manage drug therapy at home.73 
4. Knowledge 
The literature on elders' medication knowledge is 
conflicting. In general, the elderly are as knowledgeable 
about their medications as younger patients.7"4 However, 
increasing age, an increasing number of medications, and an 
increasing number of chronic diseases have all been 
inversely related to drug knowledge.7" 
Knowledge of medications was examined in elderly 
ambulatory patients by Rosenburg and colleagues.76 Of the 
100 participants between the ages of 65 to 93, less than 30% 
correctly identified common side effects, OTC medications to 
avoid, adverse reactions requiring physician intervention, 
activities to perform with caution, or proper mealtime 
administration. Only 49% of the patients knew the name of 
their prescription medication. None of the patients 
interviewed knew that antacids could cause side effects such 
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as constipation or diarrhea. Overall, the participants' 
knowledge was unrelated to the duration of drug therapy. 
In a similar study, D'Arcy investigated general 
knowledge and attitudes about medications in a group of 
ambulatory elders.6"* Fifty percent of the subjects reported 
knowing the risks involved in taking their medications; 33% 
thought personal knowledge about their medications would be 
beneficial; and 60% said they would discontinue their 
medication without medical advice if they believed it wasn't 
working. Host respondents knew little of the hazards of 
drug interactions. Even though 80% of these elders were 
taking prescription medications, they believed their drug 
usage was less than younger adults. 
Studies, in general, indicate that the elderly desire 
to learn more about their medications.7""*-7,6-00 Over 90% of 
elderly cardiac patients surveyed in a study by King and 
colleagues reported a strong interest in obtaining a greater 
amount of medication information.®1 Nicklin found that 
medication questions were second only to cardiopulmonary 
concerns in a survey of cardiology patients after discharge 
from the hospital.Ba 
5. Pharmacists' involvement 
A high incidence of drug related problems in the 
elderly has created a demand for pharmacists to educate 
elders about medications.7"* Madeline Feinberg, past 
chairperson of the APhA Academy of Pharmacy Practice and 
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Management Section on Home Health Care, suggested that 
pharmacists* involvement should evolve from drug regimen 
reviews in the nursing home to the home health care sector. 
There are 95% of disabled elderly patients living 
in the community and no one is monitoring their 
drug regimens, we need to push for more 
responsibility in this area.®3 
Significant communication problems exist between the 
elderly patient and pharmacist. In a study by Moore and 
colleagues0"*, elderly patients reported receiving less drug 
information than younger patients. Most elderly patients 
(80.1%) reported receiving no information from the 
pharmacist. Approximately 10% of patients received only 
directions for use and none reported receiving any 
information about side effects. Similarly in a study by 
Smith and colleague®55, only 20% of elderly who had 
patronized the same pharmacy for over 5 years, indicated 
that they had talked with the pharmacist at the time of the 
last prescription. Of these, only 33% of the conversations 
involved prescription related topics. Lastly, only one in 
six of those interviewed mentioned the pharmacist as a 
source of drug information. 
6. Medication issues for caregivers 
Although not the major focus of any prospective study, 
medication issues have occasionally been mentioned in the 
caregiving literature. A brief review of these studies will 
be examined. 
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To determine the number of medications required in 
relation to the health status of Alzheimer's victims, 159 
ambulatory elderly patients were assessed by Fisk and 
colleaguesPatients used an average of 2.2 medications 
per day and experienced an average of 3.4 associated medical 
problems. Most of the patients were not able to manage 
their medication regimens without the help of caregivers. 
The authors concluded and recommended that all caregivers 
receive information about their charges' medication. 
One study examined the use of psychotropic medications 
in elderly patients with Alzheimer's disease by their 
caregivers.®7 Of the 288 caregivers, most (83%) reported 
using antipsychotic medications for the patient at some 
point in the illness. Antipsychotic medications made 
caregiving more manageable for 88 (30.5%) of the caregivers. 
A controlling or calming effect was noted by 53% of 
caregivers. However, 14% reported that antipsychotic 
medications made caregiving more difficult because the 
medication caused lethargy or agitation in the patient. 
The expense of medications for both the patient and the 
elderly spouse caregiver results in additional financial 
difficulties. Silliman and colleagues reported that 
approximately 45% of caregivers considered medication 
expenses to be a financial b u r d e n . I n a related study, 
28% of spouse caregivers of COPD patients reported financial 
strains from medication expenses.-*2 
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One small study explored caregivers' views about the 
patient's medications and dealing with HCPs.®® This 
intervention study utilized a six week support group to 
reduce stress associated with caregiving. One session 
focused on general problems associated with the patient's 
medications. This sample of 16 caregivers reported 
insecurities when questioning HCPs about the patient's 
medications. However, the caregivers expressed a need to be 
informed and participate in health care planning and 
medication management. 
To date, no study has examined caregivers' decisions 
influencing the utilization or initiation of medications for 
the patient. However, one related study examined mothers' 
self-initiated treatment of childrens' symptoms with 
medications.®3 These mothers possessed and used a large 
number of both prescription and OTC medications to treat 
their children's symptoms. Both the number of medications 
on-hand and the numbers of medications administered related 
to the mother's perceived vulnerability of the child to 
illness. Pediatricians concluded self-initiated treatment 
could result in harm to the child. Similarly, detrimental 
effects could result if caregivers of the elderly possess 
and use additional medications. 
The need for further investigation of the types of 
medication information needed by the elderly spouse 
caregiver is clearly indicated by the literature review. An 
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exploration of the types of actual and perceived drug 
information needs of the elderly spouse caregiver and the 
pharmacist is described. 
III. OBJECTIVES 
The project utilized the exploratory approach of a 
medication information needs assessment to compare the 
actual medication information needs of the elderly spouse 
caregiver with the perceived needs as assessed by the 
pharmacist. The study focused upon the following 
objectives: 
1 Development of a medication information needs 
assessment instrument (that would be 
administered to the elderly spouse caregiver 
and elicit the types of drug information 
caregivers want/need to know in regard to the 
spouse's medications). 
2) Development of an instrument administered to 
pharmacists to elicit the types of drug 
information they perceive the elderly spouse 
caregiver requires. 
3) Assess the drug information needs of the 
elderly spouse caregiver and the perceived 
needs by the pharmacist. 
4) Comparison of the pharmacists'percept ions 
of drug information needs of the spouse 
caregiver with those actual needs identified 
by caregivers themselves. 
5) Identification of a profile of the elderly 
spouse caregivers most in need of drug 
counseling. 
IV. METHODOLOGY 
This study was a separate component of the Caregivers 
Support Project (CSP) funded by the Administration of Aging 
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and conducted by the University of Utah's Social Research 
Institute.*61 The CSP, a research/intervention study, was 
designed to reduce the stress and burden of elderly spouse 
caregivers. Data for this study were collected from 
November 1986 to December 1987. 
A. Model to Assess Needs 
An assessment of needs is the process of identifying 
which need(s) require(s) attention. In this context, a need 
is defined as a discrepancy between an acceptable and 
desirable condition. An assessment of needs is utilized in 
the initial formulation of programs.90 
A needs assessment is an essential component to 
determine and plan services in the area of gerontology.31-36 
Ideally, assessment is based on a conceptual scheme which 
leads to the generation of hypotheses on theoretical and 
applied issues.32 Assessment is the process of data 
collection and analysis which leads to the identification of 
problems requiring management.33'36 The primary goal of a 
needs assessment is to generate volitional solutions. 
This research project employed the methodological 
foundation of the Community Oriented Needs Assessment (CONA) 
model, developed by Keith A. Neuber.37 The CONA model was 
selected due to the two-way communication process between 
the population in need (consumer) and the service provider 
(key informant). The model allows collection of data from 
three discrete yet interrelated sources. The CONA model 
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consists of the following three components: 1) demographic 
or statistical profile of the area under investigation; 2) 
consumer survey (persons needing service in the community); 
and, 3) key informant survey (service provider). This 
approach is a direct and accurate method of obtaining valid 
and reliable data on target population needs.3* 
The demographic/statistical profile of the geographical 
area was the first source of data utilized. Demographic 
information pertinent to Utah and the Wasatch area was 
required to determine the extent of those in need of 
service. 
The second source (the consumer) of data utilized was 
elderly spouse caregivers (ESCGs). ESCGs function as the 
focal point in the CONA model to determine the importance of 
types of drug information. One problem associated with self 
assessed needs by the elderly is the relationship between 
needs and wants. Powers and colleagues demonstrated the 
elderly's self-assessed needs are much fewer than those 
expressed by "experts".3® He advocates that self-assessed 
needs are the best predictor of actual demand for services. 
Other authors have demonstrated both the validity and 
reliability of responses by the elderly to health care 
surveys. 3"*»33 
The final source of data for the CONA model is the key 
informant (service provider). Key informants are 
individuals who have direct contact with consumers (ESCG). 
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With this direct contact, key informants are presumably in a 
better position to understand the consumer's needs. A basic 
disadvantage of key informants as a source of data are the 
personal biases of the informants who tend to see and define 
needs from a personal, cultural, or professional 
perspective.®"* Pharmacists were selected as the key 
informants for this study because pharmacists have frequent 
direct contact with ESCGs and are in a pivotal position to 
provide drug information. 
B . S a m p l i n g 
1. Elderly spouse caregivers 
A sample of 107 subjects were recruited by the CSP 
between September 1986 and December 1987. Subjects were 
recruited primarily in the Wasatch area through self-
selection (media exposure), area aging agencies referrals, 
and physician or hospital discharge personnel referrals. 
Subjects, by informed consent, were invited to participate 
if they met the following criteria: age 65 or older; 
provided in-home care to a chronically ill elderly spouse 
for the previous 6 months; and reported the use of 
medications by the dependent spouse. 
2. Pharmacists 
A list of all registered pharmacists in Utah was 
obtained from the Utah State Board of Pharmacy. Sampling 
criteria of registered pharmacists for the study included: 
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residence in the Wasatch area and current practice in either 
a retail or hospital pharmacy site. 
An original sample size of 125 was estimated using 
Blalock's formula to achieve a 0.05 confidence level.100 
n = No 
1 + (No/N) 
Where: No = (t (pq)/d2 
n = sample size 
t = established confidence level 
pq = probability of selection 
d = confidence interval 
Estimating a 60% return rate, a random sample of 200 
registered pharmacists was selected by replacement from a 
computer generated random numbers table. The survey was 
mailed to the pharmacists. As the return rate declined, a 
follow-up survey was mailed to those who had not yet 
responded. 
C. Dependent Measure: Type of Medication/Drug Information 
Data were collected from both ESCGs and pharmacists on 
the importance of 21 different types of drug information 
(Appendix A: question 20; Appendix B: question 15). Both 
samples were asked to rate the level of importance on each 
type of drug information using a likert scale of 1 
(extremely important) to 5 (extremely unimportant). 
D. Independent Measures 
Data on independent variables were collected in order 
to measure their exploratory associations and correlations 
with types of drug information needs. The independent 
variables collected for the ESCGs included: medication 
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Issues - number of ESCG and patient's medications, 
responsibility for the patient's medication regimen, 
responsibility to obtain drug information, se1f-assessed 
knowledge of prescription and OTCs, compliance, and sources 
of drug information; demographic characteristics - age, 
gender, education, income, length of caregiving, and the 
probability of nursing home placement; physical and mental 
health characteristics - self-assessed health status, 
burden, strain, depression, tension, anger, fatigue, vigor, 
confusion, and confidence of understanding elderly problems; 
and the dependency of the spouse - instrumental activities 
of daily living (IADL); and the patient's type of illness 
(dementia vs non-dementia). Non-medication independent 
measures were generated and developed by the CSP project. 
These instruments are located in Appendix C. 
Independent variables measured for the pharmacist's 
survey included: age, gender, years as a licensed 
pharmacist, terminal degree, type of practice setting, 
percent of elderly patients, types of professional services 
routinely provided, perceived responsibility of providing 
drug information, perceptions of the ESCG's general 
prescription and OTC drug knowledge, perceived compliance of 
the ESCGs regarding prescription medication utilization, and 
preference of providing pharmaceutical services to different 
age groups. Operationalization of the variables are located 
in Appendix B. 
22 
E. Measurement Instruments 
1. Elderly spouse caregiver instrument 
The medication information needs assessment instrument 
for the elderly spouse caregiver (Appendix A) was developed 
to collect and evaluate the importance of 21 types of drug 
information that could be provided to ESCGs based upon 
current medication information s o u r c e s . 1 0 1 - 1 0 7 Other 
variables on the instrument were operationalized according 
to existing medication literature. 
The developed instrument was pretested for clarity, 
ambiguity, and length. CSP interviewers were trained on 
data collection protocol using the medication information 
needs assessment instrument. This standardization enhances 
inter-rater reliability. The medication needs assessment 
instrument was administered with other CSP instruments in 
the homes of the ESCGs. 
The medication information needs assessment instrument 
was designed for integration into the CSP's pre-test 
instrument package (Appendix C). To avoid repetitive 
questions, some data collected from CSP instruments were 
used for this project. These additional data were used to 
evaluate associations, correlations, similarities, and 
differences with various medication issues. A description 
of these instruments follows: 
Demographics were collected for both the caregiver and 
the patient. In addition to standard demographic 
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information, the patient's primary diagnosis (dementia vs 
non-dementia), the length of caregiving, and the probability 
of nursing home placement was collected. 
Health status of the ESCGs was determined with a single 
item. The scale was 1 (excellent) to 4 (poor). Self-
assessed health status with a single item scale correlates 
highly with physician ratings of health, and is a better 
predictor of mortality than objective health ratings.100 
The patient's health status was rated by caregivers from 
1 (excellent) to 10 (poor). 
Caregiver's Strain was measured with Robinson's 
standardized 13 item strain index.103 ESCGs responded 
either yes (1) or no (0) to the individual items. A total 
strain index was derived by calculating the 13 items. 
Burden was measured with an adapted version of Zarit's 
22 item index of burden.110 The caregiver rates items from 
1 (strongly agree) to 5 (strongly disagree). Average burden 
scores in other caregiver populations range from 35 to 45. 
The Profile of Mood State (POMS) instrument was used to 
evaluate caregiver's moods.111 POMS, a standardized 
instrument developed by the Edits Test Department, San Diego 
California, consists of 65 adjectives that describe feelings 
or mood states. The caregiver responds to the adjectives 
from 1 (not at all) to 5 (extremely). POMS measures the 
following six mood factors: tension, depression, anger, 
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vigor, fatigue, and confusion. A higher score reflects a 
greater intensity of the mood. The POMS instrument has been 
used in a number of studies. 
Patient Behavior Evaluation was used to determine the 
patient's level of dependency.112 This instrument was 
designed to collect data on independent activities of daily 
living (IADL) including: the use of a phone, a legal 
signature, writing a simple message, manipulating money, 
planning a simple budget, planning/preparing meals, planning 
a daily schedule, home maintenance skills, and the 
responsibility for their medications. Each of the items is 
scored from 1 (dependent; can't complete the task without 
assistance) to 5 (independent). 
Memory and Behavior Checklist was used to evaluate the 
patient's memory and behavior problems and their frequency. 
Items are scored from 0 (problem has never occurred) to 4 
(problem occurs daily or more often). 
Confidence in Understanding was developed to determine 
the caregiver's confidence in understanding common elderly 
problems. This 12 item index (developed by the CSP Project 
Coordinator) included questions regarding the medical and 
mental health problems, legal issues, financial issues, 
decisions about long term care, how to work appropriately 
with the patient's health care providers, and special 
medication considerations. The scale is from 1 (not at all 
confident) to 5 (very confident). 
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2. Pharmacist instrument 
An instrument to assess pharmacists' perceptions of the 
drug information needs of ESCGs was developed (Appendix B). 
The 21 types of drug information were operationalized 
identical to the ESCG's survey item on types of drug 
information to ensure comparability. Independent variables, 
discussed earlier, were incorporated in the instrument. The 
instrument was pretested with staff pharmacists at the 
University of Utah Medical Center for clarity, ambiguity, 
and length. 
F. Data Management and Analyses 
Medication data collected on ESCGs and pharmacists were 
coded and cleaned. Both instruments were designed with edge-
coding to minimize systematic error (e.g., transposing). 
Data were input directly into files on the University's 
UNIVAC 1200 mainframe. Data were manipulated through the 
Statistical Package for the Social Sciences updated version 
(SPSSX).113 Data management and analyses were under the 
supervision of the CSP's project coordinator. 
Analyses of the data were conducted in several stages 
in accordance with exploratory data analysis procedures.11* 
The first stage consisted of univariate analyses for both 
samples. This stage describes both the independent and 
dependent variables. Distribution of the means, standard 
deviations, variances, kurtosis, and skewness were 
inspected. 
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The second stage included bivariate analyses for both 
samples. Bivariate analyses tested for relationships, 
associations, correlations, and mean differences between and 
among the 21 types of drug information and independent 
variables. Bivariate analyses were conducted on each sample 
separately and then between samples. Approximate degrees of 
freedom (ADF) T-tests, analysis of variance (ANOVA), and 
Pearson's correlation coefficients (r) were used with data 
at the appropriate level of measurement. Due to the 
exploratory nature of this study, the correlations (r) with 
significant p-values are noted in the results. Categorical 
data were analyzed with non-parametric statistical tests 
(Chi-square or Fischer's Exact). The third stage of 
analyses included an exploratory factor analysis. Factor 
analysis was used to discover patterns among variations in 
the dependent variables.113 For this project, factor 
analyses were used to reduce the 21 dependent variables to a 
smaller number of either latent useful constructs, or 
patterns . 1 1 E 5 ' 1 1 S _ 1 1 3 The factor analysis began at the 
exploratory level given the current lack of existing 
literature. A confirmatory factor model was not appropriate 
for this exploratory study. 
The importance of the 21 types of drug information from 
the ESCG's instrument was initially subjected to factor 
analysis. Factors were extracted using an eigenvalue 
greater than or equal to 1.0. The extracted factors were 
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subjected to varimax rotation. Items with a factor loading 
of more than 0.48 were combined to develop the factor 
scales. A "good-fit" confirmatory factor model was tested. 
Cronbach's alpha and other reliability tests were performed 
to test for internal consistency and reliability. 
The second exploratory factor analysis was performed 
with the dependent variables collected from the pharmacists' 
survey. These data were subjected to the identical 
procedure used for the ESCG's. Factor constructs were also 
extracted with an eigenvalue of greater than one. These 
factors were subject to varimax rotation. Items loading 
over 0.48 were combined to develop the factor scales. The 
extracted factors were then used as dependent measures for 
both samples. Multivariate analyses were conducted for both 
samples to measure association, correlation, and the 
predictability of factors with independent variables. 
The ESCGs and pharmacists data were tested to identify 
similarities and discrepancies. A comparison between mean 
differences of the ESCG's ratings of the importance of the 
21 types of drug information with the pharmacists perceived 
ratings was analyzed. Two-tailed independent sample T-tests 
were used to compare significant mean differences between 
the two samples. 
The dependent variables from both the ESCGs and 
pharmacists instruments were pooled for a total sample size 
of 217 and subjected to a third, and final, factor analysis. 
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V. RESULTS 
Results of the study are presented corresponding to the 
three components of the CONA model. First, the demographic 
or statistical profile of Utah and the Wasatch area is 
discussed briefly. Second, the results from the ESCGs 
(consumer) survey are presented. The individual variables 
from the ESCGs instruments are described, then selected 
relationships and differences are presented. The third 
section presents results from the pharmacist (key informant) 
survey. 
A comparison between the ESCG and pharmacist is then 
presented. The first comparison is the difference in 
importance of the types of drug information. The second 
comparison contrasts compliance issues. Finally, a third 
exploratory factor analysis presents pooled data from both 
samples. 
A. Demographic/Statistical Profile of the Area 
An examination of the State of Utah and the Wasatch 
Valley emphasizes the growing trend of the elderly 
population in this area. Utah's elderly population 
increased by 41% between 1970 and 1980, the 11th highest 
rate of increase among the 50 states. 1 = 5 0 Population 
projections based on the 1980 census indicated an elderly 
population of 198,396 in 1985. Of these, 30,666 needed the 
help of another person to carry out daily activities. 
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Regionally, the rate of institutionalization of the elderly 
disabled population was approximately 16% per year. 
Utah's Office of Planning and Budget reported that by 
the year 1990, 5.3% of the state's population will be 
between the ages of 65 to 74; 4.2% will be between the ages 
of 75 to 84 years of age; and 1.0% will be over 85 years of 
age.t=eo By 1990, the number of elderly requiring caregivers 
is expected to reach 39,448.*® 
B. Elderly Spouse Caregivers and Patients 
1. Demographic characteristics 
This study included 104 elderly spouse caregivers 
(ESCG) with a mean age of 69.1 years. Selected demographic 
characteristics for both the ESCG and the patient are 
presented in Table 1. The typical ESCG was female, with 
slightly greater than a high school education, had several 
children, and had been married to the patient for many 
years. ESCGs had provided care to the dependent spouse for 
a range of 9 to 216 months. ESCGs reported a low 
probability of institutionalizing the dependent spouse. 
Older caregivers were more likely to be male (r = 0.32, p < 
0.0005). There was a significant difference between ESCGs 
with lower incomes and an increased probability of nursing 
home placement using Fisher's Exact Test (p < 0.05). This 
indicates that ESCGs with lower incomes were more likely to 
place the patient in a nursing home than the ESCG with 
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higher incomes. Similarly, a lower income was significant 
for a longer period of caregiving (p < 0.05). 
The patient, or dependent spouse, was older and had 
slightly more education than the caregiver. Less than half 
of the patients were demented. Older patients had an 
increased probability of nursing home placement (r = 0.22, p 
< 0.01). There was an inverse relationship between the 
patient's age and the length of caregiving (r = -0.27, p < 
0.005), indicating older patients had not necessarily been 
receiving care the longest. ESCGs of demented patients were 
significantly older than ESCGs of non-demented patients (t = 
2.82, p = 0.008). Similarly, the caregivers of non-demented 
patients were more likely to be female (t = 1.87, p = 0.06). 
2. Physical health, medication use, and psychosocial 
indicators 
Physical health, medication use, and psychosocial 
indicators for both the ESCG and patient are presented in 
Table 2. The typical caregiver reported current health as 
good to fair. One-third of the ESCGs reported their health 
had deteriorated compared to the previous year. As a direct 
result of caregiving, health had suffered for 42.3% of the 
caregivers. ESCGs with poorer self-assessed health reported 
a statistically significant higher percent probability of 
placing the patient in a nursing home (X2 = 62.74, p < 
0.003). Health was rated poorer as the length of caregiving 
increased (X2 = 118.31, p < 0.002). 
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When assessing the patient's health, none of the 
caregivers reported the patient's health as excellent and 
24.1% of the caregivers reported the patient's health as 
poor. Patient's with a non-demented type of illness had a 
poorer health status (X2 = 9.96, p < 0.04). 
Most of the caregivers reported the use of prescription 
medications (Appendix A, question 10). The number of 
prescription medications ranged from 1 to 10. OTC drug use 
was lower and ranged from 1 to 5 medications. There was a 
moderate relationship between the caregiver's self-assessed 
health status and the number of prescription medications (r 
= 0.36, p < 0.001). Psychotropic medications (antianxiety 
agents, sleeping agents, antidepressants, and other drugs 
for tension or nerves) were used by one-third of the ESCGs 
(Appendix A, question 11). Some ESCGs reported using more 
than one type of psychotropic medication. Caregivers with 
more education reported a significantly higher use of 
antianxiety medications (r = 0.21, p < 0.05). 
Nearly all of the patients used prescription 
medications. The number of reported medications ranged from 
1 to 12. OTC medications were reportedly used by more than 
half of the patients and ranged from 1 to 7. The number of 
prescription medications was moderately and significantly 
related to the use of OTC medications (r = 0.225, p = 
0.046). Older patients, those with a non-demented type of 
illness, and those in poorer health used significantly more 
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prescription medications (p < 0.05). Psychotropic 
medications were used by over half of the patients. 
Antipsychotic medications were reportedly used for 16 of the 
patients. Some of the patients used more than one type of 
psychotropic medication. 
Several psychosocial indicators for the ESCGs were 
measured using instruments from Appendix C. As can be seen 
from Table 2, although the average psychosocial profile 
described the caregiver as burdened, tense, mildly 
depressed, angry, tired, and confused, the most negatively 
reported feature of the caregiver's psychosocial status was 
strain. Individual items on the strain index as reported by 
ESCGs included: 46.2% indicated their sleep was disturbed at 
night because the patient was in or out of bed or wandering 
at night; 51.4% reported caregiving as a physical strain; 
75% reported the patient's behavior was upsetting due to 
incontinence, accusations, or problems with memory; and 
56.7% felt completely overwhelmed by their caregiving role. 
Most caregivers had slightly more than an average 
confidence of understanding elderly problems. In 
particular, one of the items on the instrument was their 
confidence in understanding special medication 
considerations (Appendix C, question 12). For this 
question, a less than average confidence was reported by 
13.6% of the ESCGs, average confidence by 31%, and more than 
average confidence by 55.4%. 
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There were no significant differences between male and 
female caregivers and depression, tension, anger, fatigue, 
or confusion. A comparison of the means using two-tailed T-
tests approached a significant difference for both strain 
(p < 0.06) and burden (p < 0.07) with female caregivers 
reporting more strain and burden than male caregivers. 
Caregivers of demented spouses reported no significant 
differences in burden, tension, depression, anger, fatigue, 
or confusion than caregivers of non-demented spouses. 
Caregivers of demented patients reported a significantly 
greater confidence in working with health care professionals 
than caregivers of non-demented patients (t = 2.49, 
p < 0.014) . 
Psychosocial indicators for the patient included an 
independent activities of daily living (IADL) instrument 
(Appendix C, Patient Behavioral Evaluation). The IADL was 
used to assess the level of patient dependency from 1 
(dependent) to 5 (independent). Fifty-one percent of the 
patients scored between one and two. Patients with a 
demented type of illness were significantly more dependent 
(t = 2.66, p < 0.009). One of the IADL items (question 5) 
was the patient's responsibility for medications. Only 26 
(28.6%) of the patients had some responsibility for their 
medications. 
The patient's memory and behavior were assessed using 
the Memory and Behavior Problem Checklist (Appendix C). The 
behavior problems exhibited by the patients included: 26.9% 
were incontinent (42 patients were dependent to some extent 
for bladder control); 32.7% woke the caregiver up every 
night; 40.4% were constantly restless and agitated; 17.3% 
experienced hallucinations or illusions, and were suspicious 
or accusative; 16.3% could not recognize familiar people; 
and 7.7% engaged in potentially dangerous activities. 
ESCGs reporting a greater number of prescription 
medications scored higher on both confusion and tension 
(p < 0.01). Those caring for a more dependent spouse used a 
greater number of medications (p <0.036). There was a 
moderate yet significant relationship between the number of 
prescription medications and the caregiver's reported 
tension, depression, anger, and confusion (p < 0.05). There 
was also a slight but significant relationship between an 
increased number of spouse's medications and higher burden 
scores (r = 0.17, p < 0.05). 
Table 3 presents a Pearson's correlation matrix of 
selected physical and psychosocial indicators. The 
correlation coefficients (r) and related significance level 
are included in the table. Patient dependency was related 
to the caregiver's confidence in working appropriately with 
health care professionals (HCP) (r = 0.26) and their 
confidence in understanding elderly problems (r = 0.19). 
There was an inverse relationship between the patient's 
dependency and the caregiver's strain (r = -0.29) and burden 
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(r = -0.26) indicating a more dependent patient may result 
in increased strain and burden for the caregiver. There was 
an inverse relationship between the patient's dependency and 
the caregiver's tension (r = -0.18), depression (r = -0.24), 
anger (r = -0.22), and confusion (r = -0.29) suggesting 
ESCGs of dependent patients were more depressed, tense, 
angry and confused. 
The caregiver's confidence in working with HCP was 
correlated with their confidence in understanding elderly 
problems (r = 0.67). There was an inverse correlation 
between their confidence in understanding elderly problems 
with reported strain (r = -0.24), burden (r = -0.36), and 
ESCG's health problems since providing care (r = -0.19), 
indicating a reduced level of confidence with an increased 
level of strain, burden, and health problems. There were 
inverse relationships between confidence in understanding 
elderly problems with tension (r = -0.17), depression 
(r = -0.17), anger (r = -0.25), fatigue (r = -0.18), and 
confusion (r = -0.25). Caregivers with a greater confidence 
of understanding reported higher scores on both vigor 
(r = 0.21) and an increased length of caregiving (r = 0.26). 
There was a significant relationship between strain and 
burden (r = 0.66) indicating the reliability of the strain 
and burden indices. Those caregivers reporting health 
problems since providing care was correlated to both strain 
(r = 0.27) and burden (r = 0.35). The ESCG's strain was 
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correlated with tension (r = 0.42), depression (r = 0.43), 
anger (r = 0.39), fatigue (r = 0.34), and confusion 
(r = 0.45). Whereas the ESCG's burden was similarly 
correlated with tension (r = 0.47), depression (r = 0.47), 
anger (r = 0.44), fatigue (r = 0.25), and confusion 
(r = 0.37). Caregivers' strain and burden index scores were 
inversely correlated with vigor (r = -0.22). There was a 
significant relationship between strain and the length of 
providing care (r = 0.24) as well as a relationship between 
the probability of nursing home placement and the burden 
score (r = 0.19). 
The ESCG's tension (r = 0.25), depression (r = 0.19), 
anger (r = 0.22), and fatigue (r = 0.25) scores were all 
related to the caregivers health problems since providing 
care to the patient. Vigor was inversely correlated with 
health problems (r = -0.28). There were significant 
relationships between the caregiver's scores on individual 
mood states with the other mood states (tension, depression, 
anger, fatigue, and confusion). An inverse relationship was 
demonstrated between confusion and the length of caregiving 
(r = -0.22) indicating less confusion as the duration of 
caregiving increased. 
3. Medication responsibility 
The responsibility to ask for drug information 
(Appendix A, question 15) was personally accepted by more 
than half of ESCGs as can be seen in Table 4. The following 
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significant relationships were found for ESCG's who thought 
the HCP should be responsible for providing all drug 
information: older caregivers (r = 0.17, p = 0.03); poorer 
health of spouse (r = 0.29, p = 0.003); and ESCGs with a 
higher confusion score (r = 0.31, p = 0.004). There was an 
inverse relationship between the patient's dependency status 
and the ESCGs responsibility to ask for drug information 
(r = -0.19, p = 0.038) . 
Most of the ESCGs reported being responsible for the 
patient's medication regimen (Appendix A, question 12). A 
similar frequency was previously reported on the IADL 
instrument. Both the patient's dependency (p = 0.006) and 
memory and behavior evaluation (p = 0.0002) were significant 
with the ESCG's being responsible for the patient's 
medication regimen. Relationships among the caregiver's 
responsibility for the patient's medication regimen 
included: older caregivers (r = 0.17, p = 0.043); female 
caregivers (r = 0.19, p = 0.03); caring for a demented 
patient (r = 0.29, p = 0.002); increased percent probability 
of nursing home placement (r = 0.26, p = 0.005); and a 
higher confusion score of ESCGs (r = 0.24, p = 0.024). 
Problems associated with administering patient 
medications were evaluated using content analysis of open-
ended responses. Fifty-nine percent of the ESCGs reported 
no problems in administering medications. Problems 
associated with administering the medication were reported 
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by 18.3%. These problems were described as the patient was 
unable to swallow or the ESCG had to crush tablets. 
Remembering to give the medication was a problem for 11.9%. 
Difficulty administrating the drug because the patient 
wouldn't (or hated) to take it was reported by 9.9%. One 
caregiver gave unusual information in response to the 
question, which was not included in analysis. 
4. Knowledge and compliance 
Self assessed general drug knowledge was measured for 
both prescription and OTC medications (Appendix A, questions 
16, 17, 18) and reported in Table 4. In general, caregivers 
rated their knowledge about prescription medications as 
higher than OTC medications. Most ESCGs reported 
prescription drug knowledge had increased since their spouse 
became ill. Younger caregivers were more likely to report 
an increase in both prescription and OTC drug knowledge 
since their spouse had become ill (r = 0.28, p = 0.003) 
compared with older caregivers. ESCGs providing care the 
longest were more likely to report increased prescription 
drug knowledge (r = 0.26, p = 0.024). The reported increase 
in OTC drug knowledge with the length of caregiving 
approached significance (r = 0.18, p = 0.06). There was a 
significant difference between an increased number of 
patient's medications and an increase in knowledge of both 
prescription (t = 3.26, p = 0.001) and OTCs (t = 2.97, 
p = 0.003) since the spouse had become ill. 
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One-third of the ESCGs reported to know more about the 
patient's medications than their own. There was a 
significant difference between ESCGs reporting a higher 
level of drug knowledge and an increase in drug knowledge 
since their spouse became ill (t = 1.99, p < 0.05). 
Significant mean differences (ANOVA) between ESCGs drug 
knowledge ratings for both prescription and OTC medications 
are presented in Table 5. An inspection of the extreme 
responses for drug knowledge as "a lot" versus "almost none" 
indicates the two most significant factors for prescription 
• 
drug knowledge are the number of patient's medications and 
the length of providing care. 
Figure 1 illustrates that most ESCGs utilize a 
physician for drug information. Caregivers reporting poorer 
health utilized the physician rather than the pharmacist for 
drug information (p = 0.02). 
Indicators of compliance with the patient's drug 
regimen are shown in Table 6. Most ESCGs reported that they 
infrequently forgot to administer the spouse's medications 
(Appendix A, question 21). Less than half of the ESCGs 
reported deciding not to use a medication prescribed by the 
physician for their ill spouse (question 19). Therefore, 
omission of doses may be related more to conscious decision-
making rather than benign forgetfulness. 
Methods used by caregivers to facilitate administration 
of medications are illustrated in Figure 2. Only 13.5% 
40 
of the caregivers desired to learn more about a method to 
enhance compliance with the spouse's medication regimen. 
There was no significant relationship between the 
number of patient's medications or ESCG's medications and 
whether or not the ESCG ever forgot to administer 
medications. There was a moderate relationship between 
forgetting to give a medication and the caregiver's health 
(r = 0.26, p = 0.004) and the patient's dependency score 
(r = 0.26, p = 0.02) . 
No significant relationship was established between the 
frequency of forgetting and the caregiver's age, education, 
income, length of caregiving, confidence of understanding 
elderly problems, probability of institutionalization, 
patient's type of illness, or the patient's dependency. 
Moderate relationships were found between the frequency of 
forgetting to administer medications and a greater burden 
(r = 0.27, p = 0.008), depression (r = 0.24, p = 0.018), 
anger (r = 0.23, p = 0.019), fatigue (r = 0.19, p = 0.046), 
and confusion (r = 0.27, p = 0.008). 
Caregivers with greater burden made significantly more 
decisions not to administer a prescribed medication to their 
spouse (p = 0.016). Increased care management skills were 
correlated with more frequent decisions not to use a 
prescribed medication for the dependent spouse (r = 0.23, 
p = 0.02). Both tension (r = 0.17, p = 0.04) and depression 
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(r = 0.18, p = 0.047) were also related to the ESCG's 
decision not to use a prescribed medication for the 
dependent spouse. Reasons cited by ESCGs who decided 
against using a prescribed medication for their spouse 
included: 57.1% worried about side effects, 28.6% determined 
the patient was already taking too many medications, 23.8% 
reported the patient didn't need it or no improvement was 
seen, 11.9% disagreed with the physician's assessment of the 
problem, 11.9% didn't know the purpose of the medication, 
4.7% feared the patient would become dependent on the drug, 
and 2.4% forgot to have the prescription filled. Multiple 
responses were cited by some ESCGs. 
5. Importance of the types of drug information 
The self-assessed importance of the specific types of 
drug information is presented in Table 7. Higher scores 
indicated a lower importance for the items. The three most 
important items were: the purpose, name, and quantity to 
administer. The cost of the medication was rated as least 
important for the caregiver. 
Analyses of mean differences were significant for ESCGs 
of demented patients who rated the risks of not giving the 
medication (t = 2.17, p < 0.047) and the cost of the 
medication (t = 2.11, p < 0.037) as more important than 
caregivers of non-demented patients. 
If the caregiver forgot to administer medications, they 
rated the following types of drug information items as 
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significantly important: name, purpose, how it works, exact 
times to give, what to do if a dose is missed, and OTCs to 
avoid (p < 0.05). 
Caregivers who decided against administering a 
prescribed medication rated the following types of drug 
information significantly more important: how the 
medication works in the body and how to recognize a side 
effect (t = 1.98, p < 0.05) . 
Table 8 compares the mean differences of the ESCG's 
perceived responsibility to obtain drug information by the 
importance rating of types of drug information. ESCGs who 
accepted the responsibility to ask for drug information 
rated over 50% of the items as more important than the ESCG 
who believed the HCP would inform them of all necessary 
information. 
6. Overall importance of drug information 
Total drug information importance was derived by 
summing and taking the average of the 21 items in question 
20 of Appendix A. Mean total drug information importance 
averaged 1.42. There was a significant relationship between 
the total drug information importance and the caregiver's 
age (r = 0.20, p = 0.05) and burden (r = 0.26, p = 0.05). 
Older and more burdened caregivers reported less total drug 
information importance. 
There was a significant difference between ESCGs who 
perceived it was their responsibility to obtain drug 
information with the total drug information importance 
(t = 1.97, p < 0.05). There was no significant difference in 
the responsibility for the patient's drug regimen and the 
total drug Information Importance. ESCGs with "a lot" of 
prescription medication knowledge reported a greater 
importance for total drug information using Fisher's Exact 
test (X2 = 79.18, df = 52, p < 0.008). 
7. Factor analysis 
An exploratory factor analysis was used to reduce the 
21 individual dependent variables (types of drug 
information) to a smaller number of latent factor 
constructs. Two items, the name (item a) and the cost (item 
r) of the medication were excluded from the factor analysis 
due to inappropriate and insufficient factor loadings. The 
ESCG's correlation matrix of importance ratings of the 
remaining 19 types of drug information is shown in Table 9. 
Lawley1113 and Maxwell113 suggest a minimum sample size 
for factor analysis of at least 51 more cases than the 
number of variables under consideration or N - n - 1 > 50, 
where N is the sample size and n is the number of variables. 
For this sample, 104 - 19 - 1 = 84. The correlation matrix 
(Table 9) was tested by the Kaiser-Meyer-Oik in (KMO) measure 
of sampling adequacy. The KMO is an index for comparing the 
magnitudes of the observed correlation coefficients to the 
magnitudes of the partial correlation coefficients (or the 
correlations between each pair of items).121 When the sum 
of squared partial correlation coefficients corresponding to 
all variables is small compared to the sum of the squared 
correlation coefficients, the KMO approaches 1.0. Briefly, 
Kaiser characterizes measures between 0.90 and 1.0 as 
"marvelous" and between 0.80 and 0.89 as "meritorious". The 
KMO for the correlation matrix in Table 9 is 0.841. 
Bartletts' test of sphericity was also performed to test the 
hypothesis that the correlation matrix is an identity matrix 
with insufficient intercorrelations in the data. When the 
value of the test statistic for sphericity (based on the chi 
square transformation of the determinant of the matrix) is 
large and the associated significance level is small, it is 
unlikely that the population matrix is an identity.122 For 
this correlation matrix, Bartletts' test of sphericity is 
1207.12 with a p < 0.00005. Therefore, the correlation 
matrix of data evaluating ESCG's drug information needs is 
not an identity matrix, and an exploratory factor analysis 
is appropriate. 
Four factors were extracted using an eigenvalue greater 
than 1.0. The four extracted factors were subjected to 
varimax rotation. Items with a factor loading of greater 
than 0.48, and theoretically justified, were combined to 
develop the factor scales. Table 10 illustrates the 19 
individual items with the four extracted factors, factor 
loadings, communality, Cronbach's alpha reliability, and the 
respective eigenvalues. The Cronbach's alpha was used to 
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measure the internal reliability of the factor scales. All 
four factor scales were determined to be reliable, with the 
lowest alpha measured on factor four as 0.721. This four 
factor exploratory model accounted for 65.2% of the total 
variance represented by the 19 individual types of drug 
information. 
Listed in Table 11 are the ESCG's factor constructs 
grouped by the type of drug information loading on each. 
Factors were given labels which generally seemed to 
summarize the type of information contained in all items. 
For example, Factor 1 was labeled side effect information 
since all six items pertained to side effects. Factor 2, 
consisting of four items, was labeled interaction 
information although item p may be extraneous. Factor 3 was 
labeled as administrative information since these six items 
pertained to administration types of drug information. 
Factor 4, consisting of three items, was labeled 
paraprofessional information because the items related to 
some of the information HCPs require in order to plan and 
monitor drug therapy effectively. 
No significant relationships were demonstrated among 
the four extracted factors and the caregiver's gender, 
health, probability of institutionalization, tension, 
depression, anger, fatigue, confusion, or the patient's 
memory and behavior evaluation. There were no correlations 
between the number of ESCG's medications with the factors. 
Table 12 presents the selected significant bivariate 
relationships measured by Pearson's correlations with the 
four extracted factors. Older and more burdened caregivers 
rated all four factors as less important. The first three 
factors were rated more important as the number of patient's 
medications increased. Interaction information was more 
important for caregivers of non-demented patients. As the 
length of caregiving increased, side effect information and 
paraprofessional information increased in importance. ESCGs 
of less dependent patients rated side effect information 
more important. ESCGs with a greater confidence in 
understanding elderly problems rated administrative 
information more important. Both side effect and 
administrative information were of greater importance for 
caregivers who had higher care management skills. ESCGs 
with more vigor rated side effect information less important 
and paraprofessional information more important. 
Mean differences between ESCGs responsibility, 
knowledge, and compliance with the four factor scales are 
presented in Table 13. Side effect information, interaction 
information, and administrative information were rated more 
important by ESCGs who felt it was their responsibility to 
obtain drug information. The importance of the 
paraprofessional factor was not statistically different 
between ESCGs who took the responsibility to obtain drug 
information or those ESCGs who believed the responsibility 
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lay with the HCP. The side effect information factor, 
administrative information factor, and paraprofessional 
information factor were rated more important by caregivers 
who reported their knowledge about prescription medications 
had increased since the patient became ill. ESCGs who were 
occasionally noncompliant rated the interaction information, 
administrative information, and the paraprofessional 
information factors more important than the side effect 
information factor. 
There were several significant differences estimated by 
Fischer-Exact Tests. ESCGs who reported "a lot" of 
prescription medication knowledge also reported a higher 
importance for all four of the factors: side effect 
information (X2 = 29.4; df = 20; p < 0.07); interaction 
information (X2 = 35.4; df = 16; p < 0.003); administrative 
information (X2 = 31.0; df = 16; p < 0.01); and 
paraprofessional information (X* = 28.9; df = 16; p < 0.05). 
Administrative information was significantly more important 
for those caregivers reporting a greater knowledge about 
OTCs (X2 = 31.8; df = 16; p < 0.01). 
C. Pharmacists 
1. Characteristics of pharmacists 
Of the total surveys mailed, 122 were returned for a 
response rate of 61%. Eight surveys were unusable because 
the pharmacists had retired or were not currently employed 
as a pharmacist, and one was returned too late for analysis. 
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A total of 113 surveys were included in the data analysis. 
An "adequate" response rate was obtained.11® 
The demographic characteristics of the sample are 
presented in Table 14. Host of the pharmacists were male 
and held a baccalaureate degree as their terminal pharmacy 
degree. They ranged in age from 25 to 70 years old and had 
been licensed from 1 to 45 years. The mean hours worked per 
week by pharmacists was 42.5 hours with the majority of 
respondents working in a retail pharmacy. Hospital and 
chain pharmacists were employed primarily at their 
respective practice sites whereas independent pharmacists 
spent an average of 73.3% of their time at primary practice 
site. The pharmacists reported an average of 29.9% of their 
clients were over the age of 65 (range 0 to 75%). 
There were no significant differences between the 
pharmacists gender and the type of practice site. Analysis 
of variance (ANOVA) among groups demonstrated a significant 
difference in age of the pharmacists and type of practice 
site. The independent pharmacists were older and hospital 
pharmacists younger (F = 4.86, p = 0.009). 
Figure 3 illustrates the percent of pharmacists 
reporting to routinely provide professional services 
(Appendix B, question 6). Routinely was defined as greater 
than 50% of the time. There were no significant differences 
between professional services provided and pharmacists' age, 
gender, number of years licensed, or type of practice site. 
Pharmacists ranked their preference for providing 
pharmaceutical service to four different age groups 
(Appendix B, question 11). As shown in Figure 5, their 
first preference was for the 35 to 64 age group. Only 10.3% 
of the pharmacists ranked the elderly as the preferred age 
group. Pharmacist's who reported a higher percent of 
elderly clients ranked the over age 65 group lowest in 
preference (r = -0.24, p = 0.04). 
Pharmacists' perceptions of ESCG responsibility for 
obtaining or physicians/pharmacists providing drug 
information is shown in Table 15 (question 9). Most 
pharmacists perceived it was the ESCG's responsibility to 
ask physicians or pharmacists questions about medications 
(64 agreed, 22 neutral, and 25 disagreed). Only seven of 
the 111 pharmacists responding to the question agreed the 
physician will tell the ESCG everything about medications 
without the caregiver having to ask, 15 were neutral, and 89 
disagreed. The majority of pharmacists (59/112) agreed they 
should tell ESCGs everything about their medications without 
the caregiver having to ask (27/112 were neutral, and 26/112 
disagreed). 
Only 7/111 Pharmacists agreed the ESCGs already had 
enough prescription medication information, 73/111 were 
neutral, and 31/111 disagreed. Eight of the 111 pharmacists 
thought ESCGs had enough general knowledge about OTCs, 
64/111 were neutral, and 39/111 disagreed. 
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2. Perceived importance of drug information types 
Analysis of the perceived importance of the types of 
drug information needs for ESCGs by the pharmacists is 
presented in Table 16. The types of drug information was 
operationalized analogous with the ESCGs to ensure 
comparability. Again, lower mean scores indicated a higher 
relative importance. 
There were no significant differences between 
pharmacists' age, years licensed, or percent of patrons over 
the age of 65, and the perceived importance of drug 
information needs. Female pharmacists rated the following 
items as significantly more important than male pharmacists 
(p < 0.05): purpose; duration of treatment; drug 
interactions; OTCs to avoid; and other food/beverages or 
drugs to avoid. 
There were no significant differences in the types of 
professional services provided and the importance of 
perceived drug information except for the pharmacists 
providing written drug information. Pharmacists who 
provided written drug information rated the following items 
as significantly more important (p < 0.05): purpose; 
duration of treatment; response onset; and handling side 
ef fects. 
Pharmacists practicing in hospitals rated the following 
items as significantly more important than pharmacists 
practicing at the other practice sites by ANOVA (p < 0.05): 
duration of treatment; desired drug action; response onset; 
and missed dose information. 
Drug information needed by ESCGs was rated by 40, or 
35.4%, of pharmacists as different from the information 
needed by their other patients. The items reported by more 
than 66% of these pharmacists include: purpose, common side 
effects, the dose, OTCs to avoid, and the risks of not 
giving the medication. The cost of the medication was rated 
as the least important similar to responses given by ESCGs. 
3. Factor analysis 
The 21 individual types of drug information needs as 
perceived by pharmacists were subjected to a similar 
exploratory factor analysis as reported previously for the 
ESCGs. The correlation matrix for the pharmacists perceived 
importance of the types of drug information needs is 
presented in Table 17. The KMO measure of sampling adequacy 
was 0.867. The Bartlett test of sphericity was 987.52 with 
a significance level of < 0.0005. As with the ESCGs factor 
analysis, items a and r were excluded due to low factor 
loadings. Four factors were extracted by varimax rotation. 
The loadings of the four factors, communality, alpha 
reliability, eigenvalues, and the percent explained variance 
are presented in Table 18. The four factors explained 62.6% 
of the total variance. Table 19 lists the types of drug 
information loading on each factor. These four factors were 
labeled in a similar manner as the ESCGs extracted factors. 
There were no significant differences between the four 
extracted factors and the pharmacists' age, years licensed, 
and percent of patients over the age of 65. Significant 
differences with the four factors are presented in Table 20. 
Female pharmacists rated all of the information factors 
except the side effect information factor significantly more 
important than male pharmacists (t = 2.13, p < 0.05). 
Pharmacists who provided written drug information rated 
paraprofessional information significantly more important 
(t = 2.11, p < 0.05). Using ANOVA, hospital pharmacists 
also reported a greater importance for the paraprofessional 
information factor (F = 3.52, p < 0.05). 
Correlations of selected indicators with the four 
extracted pharmacists factors are illustrated by a path 
diagram in Figure 5. Pharmacists who perceived it was their 
responsibility to provide drug information to ESCGs rated 
all four information factors of higher importance. 
Pharmacists who agreed the ESCG does not have enough 
prescription medication information believed side effect 
information was more important than the pharmacists who 
disagreed. Pharmacists agreeing that the ESCGs do not have 
enough information about OTC medications rated all factors 
except administrative factor significantly more important. 
D. Comparison of Elderly Spouse Caregiver with Pharmacist 
1. Importance of types of drug information 
The mean differences of types of drug information needs 
as perceived by the pharmacist and rated by the ESCG are 
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shown in Table 21. There was a statistically significant 
difference between the ESCG and the pharmacists' ratings in 
all but three of the 21 individual items using two tailed T-
tests. All items were rated significantly more important by 
ESCGs except the dose, cost, and OTCs to avoid. 
2. Compliance issues 
The reported differences between the pharmacists and 
the ESCGs regarding the caregivers decision not to 
administer a prescription medication to the dependent spouse 
is shown in Table 22. More than twice as many pharmacists 
as ESCGs indicated that decisions not to use a prescribed 
medication for the dependent spouse were often made by 
careproviders. Most pharmacists believed the primary reason 
for noncompliance related to cost of the medication. 
However, none of the ESCGs reported cost as a reason for 
deciding against using a prescription medication for the 
spouse. Most of the ESCGs reported concerns about side 
effects as the primary reason for not complying whereas 
pharmacists ranked this as a tertiary reason. 
3. Factor analysis 
A separate exploratory factor analysis was performed 
using the pooled data from both the ESCG and pharmacists (N 
= 217). The pooled correlation matrix is presented in Table 
23. The KMO measure of sampling adequacy was 0.918. 
Bartlett's test of sphericity was 2285.13 (p < 0.0005). 
Four factors were again extracted explaining 65.7% of the 
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total variance. The factor loadings, communality, alpha 
reliability, and eigenvalues are presented in Table 24. 
The types of drug information loading on each factor 
along with a comparison of the previous two factor models 
are shown in Table 25. The first two factors, side effect 
information and interaction information, were relatively 
stable among all three models (the ESCG sample, the 
pharmacist sample, and the pooled sample). The 
administration information was less stable. The 
paraprofessional factor was the least stable. In fact, this 
factor was extracted as the third factor with the pooled 
data. For all three of the separate exploratory factor 
models, side effect information accounted for most of the 
explained variance in the data. 
VI. DISCUSSION 
This study developed assessment instruments which 
evaluated the drug information needs of ESCGs from both the 
perspectives of consumer and provider. These instruments 
prospectively assessed the drug information needs using 
samples of local ESCGs and pharmacists. Additionally, the 
study identified and characterized ESCGs most in need of 
drug information. 
Overall, the results of this study demonstrated that 
ESCGs considered almost all types of drug information 
important. The mean rating for each type of drug 
information was between one and two on a five point 
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importance scale. ESCGS rated the following types of drug 
information as most important: purpose, name, dose, desired 
drug action, handling side effects, and recognizing side 
effects. The following items were of intermediate 
importance: common side effects, reporting side effects, 
side effects from too much medication, times to administer, 
risks of not administering, administering at mealtime, 
reducing side effects, response onset, missed dose 
information, how the drug works, and drug interactions. Of 
lesser importance were: duration of treatment, OTCs to 
avoid, other food/beverages to avoid, and cost. Of all the 
types of drug information the cost of the medication was 
rated as the least important type of information. 
Furthermore, these ESCGs reported cost did not influence 
their decisions whether or not to comply with medication 
prescribed for the spouse. Similar results were reported by 
Darnell and colleagues7-0 who found only 6.4% of the elderly 
in their study considered medication expense a concern. 
Likewise, Cooper and colleagues123 reported two out of 111 
elderly rated cost an issue in noncompliance. 
By exploratory factor analysis, the side effect 
information factor was the most consistent and stable. This 
factor accounted for the largest percent of explained 
variance among all 19 types of drug information. Concern 
about side effects also influenced the compliance decisions 
made by ESCG. Although side effect information accounted 
for almost half of the total drug information variance for 
these ESCGs, Moore and colleagues®"* reported the elderly in 
their study received no information about side effects from 
HCPs. 
As expected, when specific sub-populations of 
caregivers were identified, the importance of several types 
of drug information varied. Two sub-populations of ESCGs 
were identified by this study. One group appears to be 
older, more ill, more burdened by caregiving 
responsibilities, and interacts passively with HCPs. The 
other subgroup is younger, healthier, appears to find 
caregiving minimally burdensome, and actively pursues 
information from HCPs. Those in the later or "younger" 
group tended to rate all types of drug information of 
greater importance than those in the "older" group. Of 
concern, however, the older group reported the lowest self-
assessed drug knowledge and therefore appear to be those 
ESCGs most in need of drug information. 
Although this study was not designed to assess possible 
causality between interest and knowledge, the disparity 
between the two may present potential problems for health 
educators. There are risks inherent in traditional attempts 
to provide information to those patients who are not 
interested. The ESCGs in this study may be so completely 
overwhelmed with caregiving responsibilities (burden) that 
they are less likely to ask about or retain drug 
information. Goodman2"* postulated that the caregiver's 
reduced perceived need and utilization of available home 
health care services such as home nursing and respite care, 
may be due to isolation and burden. Similarly, the 
importance of drug information rated by these ESCG's may 
actually be different from their actual need. 
Also the types of drug information needs varied when 
controlling for the specific characteristics of the patient 
populations. For example, when the patient was more 
dependent, the ESCGs accepted a more active role in 
obtaining drug information. However, when the patient was in 
poorer health, the ESCG assumed a more passive position. 
ESCGs of demented patients rated the risks of not giving the 
medication and cost of the drug more importantly than ESCGs 
of non-demented patients. The non-demented patients 
utilized more medications, tended to be older, and were in 
poorer health. ESCGs of these non-demented patients 
typically had been providing care longer, reported a higher 
self-assessed prescription and OTC drug knowledge, and an 
increased importance for side effect, interaction, and 
administrative information factors. 
When patient characteristics are considered, additional 
profiles of ESCGs most in need of drug information could be 
developed. One profile is the ESCG of demented patients who 
rates the risks of not giving the medications and the cost 
more importantly. Possibly these ESCGs infer a cost to 
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benefit decision regarding medication utilization for 
symptom control in the demented spouse. Educating the ESCG 
about the appropriate purpose and effects of these 
medications may influence their decisions. A second profile 
is that of ESCGs of non-demented patients who have typically 
provided extensive periods o£ care and administered multiple 
medications. These ESCGs rate drug knowledge high and are 
interested in all types of drug information, and are more 
likely to belong to the "younger" sub-population of ESCGs 
mentioned previously. Possibly these ESCGs believe they 
have more drug knowledge due to their considerable 
) 
experience. HCPs should document the appropriateness of 
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these ESCG's drug knowledge and be willing to supplement any 
deficient information. Since these ESCGs rate most all 
types of drug information important, providing them with 
drug information may be less complicated compared to other 
profiles of ESCGs. 
Another result of this study was that drug information 
l  1 iiil 
needs are not dependent on the compliance of ESCGs. In 
general, these ESCGs reported similar compliance rates 
compared to other studies of the elder ly.6ts" 1 2 3 In 
to 
this study, no association was found between compliance and 
the number of patients' or ESCGs' medications, self-assessed 
drug knowledge, or the importance of drug information. 
Rather, compliance was inversely, or negatively, influenced 
by the caregiver's burden, health, depression, tension, and 
confusion. Other studies have also indicated that 
compliance is unrelated to drug knowledge.6B-63 Therefore, 
compliance tends to be a poor predictor of both drug 
knowledge and drug information needs but may correlate with 
negative strains of caregiving. Compliance would thus be 
enhanced by alleviating caregiving strains rather than 
provision of drug information. 
When tested against ESCGs, pharmacists consistently 
rated all 21 types of drug information of lesser importance 
Only three items were statistically nonsignificant: cost, 
dose, and OTCs to avoid. The results of the pharmacist's 
factor analyses were generally similar to the ESCG's. The 
side effect information factor again explained most of the 
variance with five of the six items loading similarly in 
both groups indicating a stable group of variables. The 
interaction and administrative information factors were 
similar with the exception of a few items. The most 
significant difference was with the paraprofessional 
information factor with only two of the items (how the 
medication works and the response onset) loading similarly. 
These dissimilarities in the paraprofessional factor may 
indicate important differences in the perceived meaning of 
the items. The ESCGs comprehension of drug information 
would be expected to be different than pharmacists. This i 
not unreasonable considering the different education and 
experience of the ESCG and the pharmacist. 
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The pharmacists surveyed in this study appeared to have 
several misconceptions regarding the ESCG's drug information 
needs. In fact, only 40% of the pharmacists perceived the 
drug information needs of the ESCG would be different than 
other clients. Perhaps the pharmacists did not sufficiently 
understand the meaning of the term "caregiver". Compared to 
almost half of the ESCGs, most all pharmacists perceived 
ESCGs decided against administering a drug prescribed for 
the spouse. Most importantly, the major reason for 
noncompliance cited by the pharmacist was cost, whereas the 
ESCG reported the primary reason was concern about side 
effects. 
A. Limitations 
There are limitations to this study that prevent 
general extrapolation of the results. The sample consisted 
of elderly spouses as the caregiver. In general, most 
caregivers are daughters with spouses accounting for only 
23% of the general caregiver population.10 This sample of 
ESCGs was self selecting and nonrandom in nature. Results 
indicate this sample to have a slightly higher income than 
other samples of familial caregivers. Additionally, the 
sample of randomly selected Wasatch area pharmacists may 
prevent results from being generalized to pharmacists in 
other parts of the United States. 
Another restriction to this study involved the 
development and utilization of original instruments to 
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assess drug information needs. The instruments were 
developed by extracting 21 types of drug information 
subsequent to an extensive review of established consumer 
drug information literature. 1 0 1- 1 0 7 In retrospect, there 
were several problems with the operationalization of certain 
variables. In the ESCG's instrument (Appendix A), the 
following questions were either poorly worded, repetitious, 
or subject to misinterpretation by the ESCG: 11, 12, 13, 14, 
16a, 17a, 18, 19, and 22. Concerning the pharmacist's 
instrument (Appendix B), question 6 resulted in an extremely 
high percent of pharmacists reporting to routinely provide 
professional services, whereas question 10 resulted in most 
all pharmacists claiming to provide care to a frail and 
disabled elder. Most importantly, ESCGs tended to 
indiscriminately rate all types of drug information 
(question 20) between 1 (extremely important) and 2 
(important). Similar problems with this item occurred in the 
pharmacist's instrument (questions 15 and 16). A preferable 
method would be to ask the ESCG to rate the importance of 
each type of drug information and then rank the ten most 
important types. This would allow for the use of 
discriminate analysis of types of drug information. 
Additionally, this study only measured perceived 
importance of the types of drug information needs of these 
ESCGs and not actual information need. Further, It was 
assumed that a higher importance rating for types of drug 
information translated into a greater need for this type of 
drug information. Related limitations included problems 
inherent with self-assessed drug knowledge. It would have 
enhanced the validity of the instrument to measure the 
ESCG's actual drug knowledge. Actual drug knowledge was not 
determined prior to or after the study and training effects 
of providing the information were not assessed. 
Lastly, there are several methodologic concerns which 
may result in additional limitations to this study. The 
ESCG's portion of the study was conducted as part of a 
larger research/intervention project. Although this 
permitted greater subject recruitment and availability of 
psychosocial indicators, this study design also resulted in 
several limitations. For example, data were collected by 
trained but nonpharmacy interviewers. The medication 
instrument needed to be designed so as to be incorporated 
into an already lengthy instrument battery. 
Regarding the pharmacists' survey, an interview may 
have elicited more information than a mailed survey 
especially since pharmacists may not have fully understood 
the term elderly spouse caregiver. Furthermore, one could 
question whether pharmacists were the most appropriate 
choice for the key informant role. This survey indicated 
that ESCGs obtained the majority of drug information from 
physicians. Thus, perhaps physicians would have proven to 
be better key informants. 
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B. Potential Applications 
This was an exploratory study examining the types of 
drug information ESCGs need as compared to information needs 
of ESCGs as perceived by pharmacists. Exploratory analysis 
is an essential prelude to confirmatory studies.12* This 
study's major contribution was an initial investigation 
towards the development of a drug information needs 
assessment instrument for caregivers. This instrument could 
be used by HCPs to provide a rapid assessment of the 
specific drug information required by caregivers. The 
provision of specific drug information would better satisfy 
the consumer's demands and possibly improve the health care 
of the patient. Additionally, a reliable method to assess 
drug information requirements would reduce the time of 
physicians, pharmacists, and other health care providers, 
resulting in more efficient use of personnel resources. 
Results also demonstrated that pharmacists may need 
specific education about careproviders. Not only should 
pharmacists be aware of their special role in elderly care, 
but also the pharmacist needs to consider their differing 
requirements for drug information. Most importantly, the 
pharmacist should be aware that the ESCG is interested in 
drug information but may not inquire. 
Particularly, this study emphasizes the need to design 
specific types of drug information for caregivers. For 
example, information should be developed for the commonly 
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prescribed drugs used in treating dementia i.e., 
antipsychotics and benzodiazepines. This information should 
take into consideration the typical characteristics of ESCGs 
of demented patients (more burden and strain) and be 
tailored to provide brief, explicit information presented in 
an interesting and easily assimilated format, 
c. Implications for Future Research 
Given the results and limitations of this study, 
several priorities for future research exist. The types of 
drug information needed by caregivers who are daughters, 
sons, or other relatives requires examination and comparison 
with the elderly spouse as the caregiver. Refinement of the 
assessment instrument is needed to reassess the validity and 
reliability of these types of drug information needs. 
The rationale for the older and more burdened 
caregivers rating most all types of drug information of 
lower importance needs further investigation. It would be 
informative to know if these ESCGs are interested in drug 
information but simply overwhelmed by the burdens of 
providing care. 
Further study of the caregiver's understanding or 
perceptions of 'side effect' types of information needs to 
be examined. One important consideration is the occurrence 
of 'side effects' in each of the items as a possible 
influence in both the ESCG's and pharmacist's ratings. 
However, side effects were cited as the primary reason for 
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ESCGs deciding against using a prescribed medication for the 
spouse. It is important to determine if side effects are 
actually occurring or if there is excessive concern. 
Further study of pharmacist's interpretations of drug 
information is required, since they rated all types of drug 
information of lower importance than ESCGs. Few pharmacists 
agreed ESCGs had enough drug information, but more 
importantly, most pharmacists neither agreed nor disagreed. 
An indifference towards the elderly needs to be understood 
in light of pharmacists' low preference to provide 
pharmaceutical services to the aged. Additionally, reasons 
for the discrepancy between pharmacists reporting that the 
physician was not adequately providing drug information to 
ESCGs, while most ESCGs reported utilizing the physician as 
their major source of drug information needs explanation. 
D. Conclusions 
In conclusion, the evaluation of drug information needs 
assessed by ESCGs and perceived by pharmacists reveals 
practical considerations for health care educators. ESCGs 
rated all types of drug information more importantly than 
pharmacists. Health care professionals must acknowledge the 
ESCG's interest in obtaining drug information. Based on 
both the ESCG and patient characteristics, several profiles 
of the ESCG in need of drug information emerged. Therefore, 
providing the ESCG with appropriate drug information 
requires a description of both the ESCG and patient. Most 
importantly, pharmacists and other HCPs need to develop 
versatile and innovative methods of providing drug 




Table 1. Demographic Characteristics of Elderly Spouse Caregivers 
(ESCGs) and Patients* 
Characteristic Number (%) Mean + SD 
Caregiver's: 






















Children (mean number) 3.7 + 2. 5 
Length of Marriage 
(mean years) 
43.7 + 13. 2 
Length of Providing Care 
(mean months) 
72.4 + 57. 2 
Probability of 
Institutionalization** 18.7 + 26, .6 
Patient's: 
Age (mean yrs) 71.7 + 10. 4 
Education (mean yrs) 12.7 + 3. 6 







* Number = 107 
** Percent range from 0 (no chance) to 100 (absolutely) 
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Table 2. Status of Health, Medication Use, and Psychosocial 
Indicators of ESCGs and Patients* 
Characteristic Number (%) Mean + . SD 
Caregiver Health Status: 
Present health" 2.3 + 0.7 
Health since one year ago*3 2.3 + 1.2 
Caregiver's Medication Utilization0: 
Used prescription drugs 79 (76 .7) 3.2 + 1.9 
Used over-the-counter drugs 60 (58 .3) 1.5 + 1.0 
Used psychotropic drugs 33 (32 .2) 
Caregiver's Psychosocial Status: 
Strain index (range 1 - IS)** 7.9 + 2.7 
Burden (range 38 - 216)" 76.7 + 31.0 
Tension (range 7 - 48)* 18.2 + 8.4 
Depression (range 15 - 75)r 28.3 + 12.8 
Anger (range 12 - 60)r 20.4 + 9.7 
Fatigue (range 7 - 35)* 16.3 + 6.9 
Confusion (range 5 - 31)* 12.3 + 5.3 
Confidence of understanding 
elder's problems (range 1.3 - 5)« 3.2 + 0.7 
Patient's Health Status1"1: 7.7 + 2.1 
Patient's Medication Utilization^: 
Used prescription drugs 102 (98 .1) 3.9 + 2.2 
Used over-the-counter drugs 57 (55.3) 1.8 + 1.3 
Used psychotropic drugs 60 (57 .4) 
Patient's Psychosocial Status: 
Dependency1 2.5 + 1.4 
Memory and Behavior Evaluation-3 2.0 t 0.8 
Number = 107 
•** Self-assessed health scale 1 (excellent) 4 (poor)10® 
Scale was 1 (better) 2 (worse) 3 (the same) 
•= ESCGs reported use 
* 13 item index, total strain derived from the sum 1 0 3 
~ 29 item index, 1 (strongly agree) to 5 (strongly disagree)110 
r Profile of Moods States (POMS), 65 adjectives describing six 
moods 1 (not at all) to 5 (extremely)111 
° 12 item index 1 (not at all confident) to 5 (very confident) 
M Assessed by ESCGs, scale 1 (excellent) to 10 (poor) 
1 10 item Instrumental Activity of Daily Living 1 (dependent) to 
5 (independent)112 
J 29 memory and behavior problems, 0 (problem has never occured) 
to 4 (problem occurs daily or more often) 
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T a b l e 3 . P e a r s o n ' s C o r r e l a t i o n C o e f f i c i e n t M a t r i x o f S e l e c t e d E S C f i ' s P h y s i c a l and P s y c h o s o c i a l I n d i c a t o r s * 
I n d i c a t o r 
C o n f i d e n c e 
v i t h HCPs* 
C o n f i d e n c e 
u n d e r s t a n d i n g 
e l d e r ' s g r o b l e t s * 
S t r a i n * 
B u r d e n * 
H e a l t h problems 
s i n c e c a r e g i v i n g ' 
T e n s i o n * 
D e p r e s s i o n * 
A n g e r * 
V i g o r * 
F a t i g u e * 
C o n f u s i o n * 
Prob o f i n s t . " 
l e n g t h o f 
c a r e g i v i n g ' 
P a t i e n t d e p e n d e n c y 
0.261 
C o n f i d e n c e w i t h HCPs 
, 1 9 * 0 . 6 7 * 
C o n f i d e n c e u n d e r s t a n d i n g e l d e r ' s i r o b l e t s 
, 2 9 M - 0 . 2 0 * - 0 . 2 4 " 
S t r a i n 
2 6 " - 0 . 2 4 " - 0 . 3 6 " 0 . 6 6 " 
Burden 
02 - 0 . 2 2 » - 0 . 1 9 * 0 . 2 7 " 0 . 3 5 * * 
H e a l t h a r o b l e e s s i n c e c a r e g i v i n g 
, 1 8 * - 0 . M - 0 . 1 7 * 0 . 4 2 " 0 . 4 7 * * 0 . 2 5 * 
Tension 
2 4 " - 0 . 1 9 * - 0 . 1 7 * 0 . 4 3 " 0 . 4 7 " 0 . 1 9 * 0 . 8 4 " 
D e p r e s s i o n 
, 2 2 * - 0 . 2 7 * * - 0 . 2 5 * 0 . 3 9 " 0 . 4 4 " 0 . 2 2 * 0 . 6 8 " 0 . 7 9 * * 
Anger 
15 0 . 2 4 * * 0 . 2 1 * - 0 . 2 2 * - 0 . 2 2 * - 0 . 2 8 " - 0 . 3 7 " - 0 . 3 6 " - 0 . 3 0 " 
V i g o r 
16 - 0 . 1 7 * - 0 . 1 8 * 0 . 3 3 " 0 . 3 4 " 0 . 2 5 * 0 . 6 9 " 0 . 6 7 " 0 . 5 8 " - 0 . 4 6 * 
F a t i g u e 
, 2 9 * * - 0 . 2 5 " - 0 . 2 5 * 0 . 4 5 " 0 . 3 7 " 0 . 0 5 0 . 6 9 * * 0 . 7 6 * * 0 . 6 4 " - 0 . 3 8 * 0 . 5 5 " 
C o n f u s i o n 
, 1 1 0 . 0 5 - 0 . 0 2 - 0 . 1 4 0 . 1 9 * 0 . 1 3 - 0 . 0 2 - 0 . 0 6 - 0 . 0 5 - 0 . 0 3 - 0 . 0 8 - 0 . 0 3 Prob. inst. 
1 7 0 . 1 6 0 . 2 6 * - 0 . 2 4 * - O . O f l 0 . 0 9 - 0 . 1 4 - 0 . 1 8 * - 0 . 1 9 * 0 . 1 5 - 0 . 0 9 - 0 . 2 2 " 0 . 0 2 
« H - 107 
* 1 2 i t e a i n d e x , 1 ( n o t a t a l l c o n f i d e n t ) t o 5 ( v e r y c o n f i d e n t ) 
« 1 0 i t e a I n s t r u m e n t a l A c t i v i t y o f D a i l y L i v i n g ( I A D L ) s c a l e ; 1 ( d e p e n d e n t ) t o 5 ( i n d e p e n d e n t ) ' " 
* 13 i t e e i n d e x , yes ( 1 ) or no ( 0 ) , t o t a l s t r a i n d e r i v e d f r o * t h e sue o f r e s p o n s e s ' * * 
* 29 i t e a i n d e x , 1 ( s t r o n g l y a g r e e ) t o 5 ( s t r o n g l y d i s a g r e e ) " 0 
' s c a l e was 1 ( b e t t e r ) 2 (worse) 3 ( t h e s a t e ) 
* P r o f i l e o f Hoods S t a t e s ( P 0 K S ) , 65 a d j e c t i v e s d e s c r i b i n g s i x eoods, 1 ( n o t a t a l l ) t o 5 ( e x t r e a e l y ) ' " 
* p e r c e n t range o f t h e p r o b a b i l i t y o f i n s t i t u t i o n a l i z i n g t h e spouse, 0 (no chance) t o 100 ( a b s o l u t e l y ) 
' L e n g t h o f t i e e i n a o n t h s o f p r o v i d i n g c a r e 
* p < 0 . 0 5 
" p < 0 . 0 0 5 
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Table 4. Medication Responsibilities and General Knowledge of ESCGs* 
Responsibility or Knowledge Number (%) 
Responsibility: 
Perceived responsibility to ask or 
be told drug information 
ESCG will ask 63 (61.2) 
HCP will tell 39 (37.9) 
Responsibility for patient's drug regimen 
Patient 26 (25.0) 
ESCG 78 (75.0) 
Medication Knowledge: 
Prescription drugs 
A lot 27 (26.2) 
Average 59 (57.3) 
Almost none 17 (16.5) 
Non-prescription drugs 
A lot 23 (22.5) 
Average 40 (39.2) 
Almost none 39 (38.2) 
* N = 104 
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Table 5. Significant Mean Differences Between ESCG Drug Knowledge 
Ratings by Selected Indicators 
Pryg Knowledge" 
Indicator A Lot Average Almost None 
Mean + SD Mean + SD Mean + SD F-value 
Prescription Drug Knowledge: 
Caregiver 
education 
(mean yrs) 14.18 + 6.47 11.58 + 3.89 13.00 + 2.06 3.13* 
Caregiver 
gender 
(m=l,F=0) 0.48 + 0.51 0.23 + 0.42 0.37 + 0.50 2.92* 
Length of 
caregiving 
(mean mos) 109.23 + 71.66 55.56 + 38.48 54.27 + 50.22 10.04* 
I of patient 
medications 4.08 + 1.90 2.76 + 1.97 2.58 + 1.51 4.25* 
Non-prescription Drug Knowledge: 
Caregiver age 
(mean yrs) 66.43 + 6.68 68.70 ± 9.87 71.34 ± 7.64 2.56** 
Length of 
caregiving 
(mean mos) 107.83 + 77.13 49.35 ± 37.71 67.23 + 43.62 8.61* 
Patient illness 
(l=dementia, 
2=nondem) 1.69 + 0.47 1.50 + 0.51 1.37 + 0.49 3.18* 
Noncompliance 
(l=once/mo, 
5=daily) 1.50 + 0.68 1.45 + 0.72 1.96 + 0.99 3.11* 
I of patient 
medications 4.11 ± 2.02 2.83 + 1.55 2.85 + 2.23 2.96* 
* p < 0.05 
** p < 0.10 
• ESCGs were asked to rate their general knowledge of prescription and 
non-prescription medication; 1 (a lot), 2 (average), 3 (almost none) 
Table 6. ESCG's Compliance Indicators of Patient's Drug Regimens 
Compliance Indicator Number~(%) 
Forget to administer 
patient's medications 
No 24 (23.3) 
Yes 79 (76.7) 
Frequency of forgetting 
Once per month 45 (57.0) 
2-3 times per month 19 (24.1) 
Once per week 13 (16.5) 
~ " '• • * ( 2.5) Ulltc ^ICl WCCH 1J 2-3 times per week 2 
Decide not to administer a 
prescribed medication 
No 61 (59.2) 
Yes 42 (40.8) 
* Number indicates those responding to the questions 
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Table 7. ESCG's Ratings of the Importance of Types of Drug 
Information Needs" 
Summated 
Type of Drug Information Need13 Mean ± SD Score0 (rank) 
a. The name of the medication 1. 24 t 0. 55 129 ( 2. 5) 
b. The purpose of the medication 1. 16 + 0. 39 121 ( 1 ) 
c. How long will they be taking the drug 1. 54 + 0. 74 160 (18 ) 
d. How the medication works in the body 1. 48 + 0. 69 154 (16. 5) 
e. How to know if the drug is having 
the desired effects 1. 29 + 0. 53 134 ( 4. 5) 
f. When to expect to observe results 1. 45 + 0. 67 151 (14 ) 
q. The exact times of day to give the drug 1. 34 + 0. 53 139 ( 9. 5) 
h. The quantity to give at each time 1. 24 + 0. 45 129 ( 2. 5) 
i. Should the medication be given with 
food or on an empty stomach 1. 36 + 0. 57 141 (12 ) 
j. Common side effects that may occur 1. 32 + 0. 54 137 ( 7 ) 
k. How to recognize a possible side effect 1. 31 ± 0. 52 136 ( 6 ) 
1. What exactly to do about a side effect 1. 29 ± 0. 49 134 ( 4. 5) 
m. Ways to reduce a possible side effect 1. 38 ± 0. 56 144 (13 ) 
n. Side effects that need to be reported 1. 34 ± 0. 57 139 ( 9. 5) 
0. Side effects from too much medication 1. 34 ± 0. 55 139 ( 9. 5) 
P- The risks of not giving the medication 1. 34 ± 0. 62 139 ( 9. 5) 
q. What to do if a dose is missed 1. 46 ± 0. 61 152 (15 ) 
r. The cost of the medication 2. 25 ± 0. 94 234 (21 ) 
s. Any problems or interactions with a new 
drug and other drugs currently used 1. 48 + 0. 61 154 (16. 5) 
t. Over-the-counter medications to avoid 1. 56 + 0. 67 162 (19 ) 
u. Other food, beverages, or drugs to avoid 1. 58 ± 0. 63 164 (20 ) 
- N = 104 13 Types of drug information rated on a likert scale, 
1 (extremely important) to 5 (extremely unimportant) 
"= Summated score derived from summing responses from all ESCGs 
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Table 8. Mean Differences ESCG's Perceived Responsibility in Obtaining Drug 
Information by Ratings of Importance of Types of Drug Information 
ESCG HCP 
asksb provides11 
Type of Drug Information" Mean + SD Mean + SD T-value 
a. The name of the medication 1. 16 + 0.45 1.38 + 0. 67 2.04** 
b. Purpose of the medication 1. 09 +_ 0. 30 1.26 +_ 0. 51 2.34** 
c. How long they will be taking 
the medication 1. 46 + 0. 71 1.69 + 0. 71 1.55 
d. How the medication works 1. 44 + 0.61 1.56 + 0. 82 0.84 
e. How to know if the drug is 
having the desired effects 1. 22 + 0. 45 1.41 + 0. 64 1.73 
f. When to expect to observe results 1. 42 + 0. 71 1.51 + 0. 60 0.62 
g- Exact times of day to give the drug 1. 29 +_ 0. 49 1.44 4 0. 59 0.62 
h. Quantity to give at each time 1. 19 0. 44 1.33 + 0. 48 1.38 
i. Should the medication be given 
with food or on an empty stomach 1. 32 + 0. 50 1.44 £ 0. 68 1.01 
j. Common side effects that may occur 1. 24 £ 0. 49 1.46 + 0. 60 2.03** 
k. How to recognize a possible side effect 1. 21 0. 45 1.49 + 0. 60 2.70** 
1. What exactly to do about a side effect 1.19 + 0. 44 1.46 + 0. 56 2.75** 
m. Ways to reduce a possible side effect 1. 30 i 0. 53 1.54 + 0. 60 2.09** 
n. Side effects that needs to be reported 1. 25 + 0. 57 1.49 i 0. 56 2.03** 
0. Side effects from too much medication 1. 24 + 0. 53 1.51 + 0. 56 2.50** 
P- Risks of not giving the medication 1. 21 + 0. 48 1.56 i 0. 75 2.93** 
q- What to do if a dose is missed 1. 44 i 0. 61 1.51 + 0. 60 0.55 
r. Cost of the medication 2. 11 + 0. 95 2.54 + 0. 85 2.29** 
s. Any problems/interactions with a new 
drug and other drugs currently used 1. 39 + 0. 61 1.64 0. 58 2.00** 
t. Over-the-counter medications to avoid 1. 49 i 0. 69 1.69 ± 0. 61 1.48 
u. Other food/beverages/or drugs to avoid 1. 52 + 0. 64 1.69 + 0. 61 1.31 
m Types of drug information rated with a likert : scale ! 1 (extremely important) 
to 5 (extremely unimportant) 
b N = 63, ESCG is reponsible for obtaining drug information 
" N = 39, HCP will provide all necessary drug information 
— p < 0.05 
Table 9. Correlation Matrix of Individual Iaportance Ratings of ESCG's Drug Inforaation Needs' 
B 8 
C 0.294 C 
D 0.380 0.437 D 
E 0.509 0.293 0.328 E 
F  0.269 0.548 0.343 0.476 F 
G 0.472 0.326 0.345 0.304 0.306 6 
H 0.537 0.337 0.246 0.314 0.378 0.549 H 
I 0.382 0.393 0.297 0.233 0.363 0.240 0.417 I 
J 0.432 0.320 0.208 0.484 0.564 0.264 0.437 0.381 J 
K 0.317 0.372 0.203 0.479 0.516 0.252 0.506 0.603 0.711 K 
L 0.399 0.341 0.297 0.416 0.424 0.327 0.511 0.558 0.700 0.777 I 
H 0.411 0.315 0.217 0.435 0.334 0.277 0.320 0.475 0.549 0.584 0.746 H 
N 0.314 0.282 0.176 0.381 0.389 0.199 0.439 0.434 0.625 0.662 0.651 0.594 N 
0 0.412 0.291 0.258 0.459 0.322 0.438 0.413 0.448 0.579 0.581 0.672 0.706 0.783 0 
P 0.289 0.238 0.252 0.351 0.264 0.361 0.299 0.235 0.315 0.278 0.314 0.295 0.366 0.492 P 
0 0.329 0.243 0.067 0.455 0.320 0.326 0.300 0.193 0.493 0.405 0.425 0.499 0.447 0.402 0.333 0 
S 0.396 0.175 0.228 0.377 0.322 0.215 0.318 0.341 0.445 0.324 0.438 0.448 0.455 0.412 0.367 0.446 S 
T 0.313 0.213 0.358 0.281 0.302 0.232 0.260 0.315 0.391 0.227 0.331 0.381 0.372 0.384 0.413 0.342 0.651 T 
U 0.239 0.368 0.333 0.249 0.319 0.282 0.359 0.579 0.365 0.485 0.423 0.488 0.561 0.607 0.492 0.311 0.483 0.679 
N - 104 (iteas a and r were excluded) 











K 0.849 0.829 
L 0.809 0.783 
N 0.774 0.732 
J 0.727 0.694 
M 0.716 0.659 
0 0.668 0.690 
T 0.848 0.783 
U 0.728 0.829 
S 0.683 0.636 
P 0.579 0.482 
B 0.693 0.611 
G 0.665 0.590 
E 0.642 0.568 
Q 0.527 0.592 
H 0.492 0.521 
I 0.548 0.648 
C 0.723 0.617 
D 0.681 0.616 
F 0.483 0.512 
Alpha 0.920 0.811 0.762 0.726 
Eigenvalue 8.216 1.544 1.428 1.204 12.39 
% Variance 43.2% 8.1% 7.5% 6.3% 65.2% 
* N = 104 
• Items are from individual types of drug information (items a and 
r excluded) 
Table 11. Factor Constructs Grouped by ESCG's Types of Drug 
Information Needs* 
Factor 1: Side Effect Information 
k. How to recognize a possible side effect 
1. What exactly to do about a side effect 
n. Side effects that need to be reported 
j. Common side effects that may occur 
m. Ways to reduce a possible side effect 
0. Side effects from too much medication 
Factor 2: Interaction Information 
t. Over-the-counter medications to avoid 
u. Other food/beverages/drugs to avoid 
s. Any problems/interactions with a new 
drug and other drugs currently used 
p. Risks of not giving the medication 
Factor 3: Administrative Information 
b. Purpose of the medication 
g. Exact times of day to give the drug 
e. How to know if the drug is having the 
desired effects 
q. What to do if a dose is missed 
h. Quantity to give at each time 
1. Should the medication be given with 
food or on an empty stomach 
Factor 4: Para-Professional Information 
c. How long they will be taking the medication 
d. How the medication works in the body 
f. When to expect to observe results 
* N = 104 (items a and r excluded) 
Table 12. Significant Correlations of Indicators with the Four 
Extracted Factors* 
Indicator Factor 1 Factor 2 Factor 3 Factor 4 
Side Effect Interaction Admin. Paraprof 
Information Information Information Information 
ESCG's age 
(mean yrs) 0.20* 0.18* 0.15** 
Type of illness 
(l=dementia, 
2=nondem) -0.06 -0.16** -0.04 
Length of 
caregiving 
(mean mos) -0.14** -0.02 -0.12 
Patient's 
medications 
(mean number) -0.22* -0.17** -0.26* 
Dependency 




5=confident) -0.11 -0.02 -0.24* 
Burden 
(perceived) 0.17* 0.23* 0.35* 









• Pearson's correlation coefficients of the extracted factors 
N = 104. 
* p < 0.05 
** p < 0.10 
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Table 13. Mean Differences of Responsibility , Knowledge, and Compliant 
Indicators with the Four Factors 
Indicators Mean + SD Mean ± SD T-value* 
Responsibility to Obtain Drua Information 
ESCG HCP 
Factor 1: Side Effect 1.24 ± 0.43 1.49 ± 0.47 -2.79* 
Factor 2: Interaction 1.40 + 0.49 1.65 ± 0.50 -2.42* 
Factor 3: Administrative 1.25 ± 0.31 1.39 + 0.43 -2.01* 
Factor 4: Paraprofessional 1.41 + 0.46 1.55 + 0.55 -1.37 
PrescriDtion Druq Knowledge Increased 
Since Patent Became 111 
No Yes 
Factor Is Side Effect 1.54 + 0.57 1.28 + 0.41 2.48* 
Factor 2: Interaction 1.62 + 0.49 1.47 + 0.51 1.24 
Factor 3: Administrative 1.51 + 0.46 1.25 ± 0.31 2.59* 
Factor 4: Paraprofessional 1.67 + 0.61 1.41 + 0.45 2.27* 
Forqet to Give Patient Medications 
No Yes 
Factor 1: Side Effect 1.39 ± 0.52 1.31 + 0.44 0.66 
Factor 2: Interaction 1.68 + 0.57 1.44 + 0.48 2.07* 
Factor 3: Administrative 1.50 + 0.51 1.24 + 0.29 3.16* 
Factor 4: Paraprofessional 1.61 + 0.53 1.42 ± 0.49 1.71* 
* p < 0.05 
Table 14. Demographic Characteristics of Pharmacists* 
Characteristics Number (%) Mean + SD 
Age 
(mean yrs) 41.5 + 12.32 
Gender 
Male 82 (73.2) 
Female 31 (26.8) 
Licensed 
(mean yrs) 16.1 + 12.39 
Degree 
B.S. 99 (87.6) 
M.S. 4 ( 3.5) 
Pharm.D. 4 ( 3.5) 
Other 6 ( 5.3) 
Practice Site 
Hospital 38 (36.9) 
Independent 21 (20.4) 
Chain 44 (42.7) 
Other 10 ( 8.8) 
Patrons Over 65 
(mean percent) 29.9 1 19.25 
* Number of Pharmacists = 113 
Table 15. Pharmacist's Perceptions of ESCG's Responsibility to Obtain 
Drug Information and Their General Drug Knowledge* 
Perceived Responsibility: 
ESCG's responsibility to ask physician/ 
pharmacist about medications 
Physician will tell ESCG 
Pharmacist should tell ESCG 
Perceived Drug Knowledge: 
ESCGs have enough information about 
prescription medications 
ESCGs have enough information about 
over-the-counter medications 
Mean • SD** 
2.55 ± 1.11 
4.01 + 0.94 
2.62 ± 1.01 
4.20 ± 0.59 
4.26 + 0.64 
* N = 113 
** All questions rated on a scale from 1 (strongly agree) 
to 5 (strongly disagree) 
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Table 16. Pharmacist's Perceptions of the Importance of Types of Drug 
Information Needs for ESCGs* 
Summated 
Type of Drug Information" Mean ± SD Score" (Rank) 
a. The name of the medication 1.65 + 0. 83 179 ( 4 
b. The purpose of the medication 1.29 + 0. 56 146 ( 2 
c. How long will they be taking the drug 1.84 f 0.74 206 (11 
d. How the medication works in the body 2.82 + 0. 83 319 (21 
e. How to know if the drug is having 
the desired effects 2.09 + 0. 80 234 (17 
f. When to expect to observe results 2.11 + 0. 74 238 (19 
g- The exact times of day to give the drug 1.74 + 0. 72 195 ( 8 
h. The quantity to give at each time 1.29 + 0. 49 144 ( 1 
i. Should the medication be given with 
food or on an empty stomach 1.59 + 0. 59 178 ( 3 
j. Common side effects that may occur 1.79 + 0. 66 199 (10 
k. How to recognize a possible side effect 1.96 ± 0. 71 218 (16 
1. What exactly to do about a side effect 1.90 + 0. 68 213 (14 
m. Ways to reduce a possible side effect 1.93 + 0. 69 216 (15 
n. Side effects that need to be reported 1.61 + 0. 65 182 ( 5 
0. Side effects from too much medication 1.88 + 0. 72 209 (13 
P- The risks of not giving the medication 1.85 + 0. 75 206 (11 
q- What to do if a dose is missed 2.17 t 0. 79 236 (18 
r. The cost of the medication 2.34 + 0. 91 255 (20 
s. Any problems or interactions with a new 
drug and other drugs currently used 1.66 + 0. 61 184 ( 6 
t. Over-the-counter medications to avoid 1.71 + 0. 61 188 ( 7 
u. Other food, beverages, or drugs to avoid 1.77 + 0. 67 195 ( 8 
* N = 113 
~ Pharmacists were asked to rate importance of providing each type of 
drug information to ESCGs. All types of drug information were 
rated on a likert scale, 1 (extremely important) to 
5 (extremely unimportant) 
13 Summated score derived from total responses of all pharmacists 
(lower number indicates more importance) 
Table 17. Correlation Hatrii of Individual Iaportance Ratings of Pharaacists' Perceptions of ESCG's Drug Inforaation Needs* 
B B 
c 0.261 C 
D 0.458 0.258 D 
E 0.327 0.294 0.406 E 
F 0.421 0.390 0.398 0.610 F 
6 0.139 0.309 0.249 0.411 0.336 6 
H 0.125 0.349 0.110 0.307 0.219 0.516 
I 0.085 0.319 0.171 0.373 0.298 0.424 
J 0.116 0.211 0.251 0.288 0.367 0.365 
K 0.1B3 0.194 0.249 0.419 0.521 0.370 
L 0.283 0.306 0.253 0.427 0.589 0.350 
n 0.306 0.205 0.305 0.368 0.365 0.359 
N 0.095 0.129 0.087 0.343 0.219 0.262 
0 0.184 0.321 0.306 0.329 0.424 0.273 
p 0.214 0.318 0.214 0.472 0.283 0.436 
0 0.175 0.323 0.288 0.398 0.384 0.383 
s 0.261 0.212 0.258 0.304 0.209 0.328 
T 0.109 0.127 0.131 0.346 0.274 0.354 
u 0.104 0.225 0.127 0.389 0.330 0.392 
0.560 I 
0.295 0.407 J 
0.262 0.371 0.654 K 
0.325 0.366 0.470 0.679 L 
0.324 0.409 0.475 0.599 0.631 N 
0.242 0.232 0.338 0.399 0.399 0.417 
0.274 0.332 0.405 0.519 0.578 0.504 
0.384 0.336 0.178 0.328 0.393 0.326 
0.280 0.396 0.545 0.555 0.528 0.412 
0.264 0.330 0.336 0.258 0.172 0.298 
0.282 0.256 0.271 0.327 0.337 0.330 
0.392 0.364 0.319 0.416 0.381 0.350 
N 
0.481 0 
0.424 0.539 P 
0.481 0.566 0.567 Q 
0.425 0.384 0.437 0.365 S 
0.430 0.459 0.452 0.484 0.618 T 
0.446 0.433 0.482 0.507 0.546 0.753 
» N = 113 (iteas a and r excluded) 
Table 18. Varimax Rotated Factor Matrix for 19 Types of ESCG'S Drug 
Information as Perceived by Pharmacists* 
Item" Factor Factor Factor Factor Communality (h) 
1 2 3 4 
K 0.843 0.780 
L 0.767 0.720 
J 0.726 0.601 
M 0.681 0.583 
0 0.559 0.584 
Q 0.552 0.602 
T 0.844 0.756 
U 0.764 0.703 
S 0.756 0.639 
P 0.611 0.568 
N 0.590 0.540 
H 0.819 0.725 
I 0.718 0.643 
G 0.654 0.568 
C 0.524 0.464 
B 0.798 0.647 
D 0.743 0.585 
F 0.620 0.642 
E 0.539 0.544 
Alpha 0.877 0.832 0.715 0.739 
Eigenvalue 7.440 1.747 1.396 1.312 11.89 
% Variance 39.2% 9.2% 7.3% 6.9% 62.6% 
* N = 113 
* Items are individual types of drug information (items a and 
r excluded) 
Table 19. Factor Constructs Grouped by Pharmacists' Perception 
of ESCG's Heeded Types of Drug Information* 
Factor 1: Side Effect Information 
k. How to recognize a possible side effect 
1. What exactly to do about a side effect 
j. Common side effects that may occur 
m. Ways to reduce a possible side effect 
0. Side effects from too much medication 
g. What to do if a dose is missed 
Factor 2: Interaction Information 
t. Over-the-counter medications to avoid 
u. Other food/beverages/drugs to avoid 
s. Any problems/interactions with a new 
drug and other drugs currently used 
p. Risks of not giving the medication 
n. Side effects that need to be reported 
Factor 3: Administrative Information 
h. Quantity to give at each time 
1. Should the medication be given with food 
or on an empty stomach 
g. Exact times of day to give the drug 
c. How long they will be taking the medication 
Factor 4: Para-Professional Information 
b. Purpose of the medication 
d. How the medication works in the body 
e. How to know if the drug is having the 
desired effects 
f. When to expect to observe results 
* N = 113 
Table 20. Significant Mean Differences of Selected Variables and 














Male NS 1.79 + 0.52 1.67 ± 0.48 2.14 ± 0.58 
Female NS 1.51 + 0.43 1.45 + 0.43 1.92 + 0.57 
Provide written 
information** 
No NS NS NS 2.18 ± 0.64 
Yes NS NS NS 1.94 + 0.49 
Practice site*** 
Hospital NS NS NS 1.88 + 0.51 
Independent NS NS NS 2.20 + 0.57 
Chain NS NS NS 2.19 + 0.61 
N = 113 
** T-value, p < 0.05 
*** F-value, p < 0.05 
NS Not significant 
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Table 21. Mean Differences of Types of Drug Information Needs Between 
Pharmacists and ESCGs 
Type of Information* Pharmacists" ESCGsc 
Mean + SD Mean + SD T-value 
a. The name of the medication 1. 65 4 0. 83 1. 24 4 0. 55 4.30** 
b. The purpose of the medication 1. 29 + 0. 56 1. 16 + 0. 39 1.96* 
c. How long will they be taking the drug 1. 84 + 0. 74 1. 54 + 0. 74 2.99** 
d. How the medication works in the body 2. 82 + 0. 83 1. 48 + 0. 69 12.88** 
e. How to know if the drug is having 
the desired effects 2. 09 + 0. 80 1. 29 + 0. 53 8.71** 
f. When to expect to observe results 2. 11 + 0. 74 1. 45 + 0. 67 6.84** 
g- The exact times of day to give the drug 1. 74 + 0. 72 1. 34 + 0. 53 4.67** 
h. The quantity to give at each time 1. 29 + 0. 49 1. 24 + 0. 45 0.71 
i. Should the medication be given with 
food or on an empty stomach 1. 59 + 0. 59 1. 36 + 0. 57 2.94** 
j. Common side effects that may occur 1. 79 0. 66 1. 32 + 0. 54 5.73** 
k . How to recognize a possible side effect 1.96 + 0. 71 1. 31 + 0. 52 7.66** 
1. What exactly to do about a side effect 1. 90 + 0. 68 1. 29 + 0. 49 7.50** 
m. Ways to reduce a possible side effect 1.93 + 0. 69 1. 38 + 0. 56 6.30** 
n. Side effects that need to be reported 1. 61 + 0. 65 1. 34 + 0. 57 3.30** 
0. Side effects from too much medication 1. 88 + 0. 72 1. 34 + 0. 55 6.20** 
P- The risks of not giving the medication 1. 85 + 0. 75 1. 34 + 0. 62 5.53** 
q. What to do if a dose is missed 2. 17 + 0. 79 1. 46 + 0. 61 7.28** 
r. The cost of the medication 2. 34 + 0. 91 2. 25 + 0.94 0.71 
s. Any problems or interactions with a new 
drug and other drugs currently used 1. 66 + 0. 61 1. 48 + 0. 61 2.13* 
t. Over-the-counter medications to avoid 1. 71 + 0. 61 1. 56 + 0. 67 1.73 
u. Other food, beverages, or drugs to avoid 1. 77 + 0. 67 1. 58 + 0. 63 2.19* 
• All types of drug information were rated on a likert scale, 
1 (extremely important) to 5 (extremely unimportant) 
b N = 113 Pharmacists 
•= N = 104 ESCGs 
* p < 0.05 
** p < 0.005 
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Table 22. Reported Differences Between Pharmacists and ESCGs in Regard 
to ESCG's Decision Not to Use/Obtain a Prescription 
Medication for the Patient and the Reasons Ranked 




Decision to administer a drug 







Ranked major reasons: 
Couldn't afford it 1 8 
Didn't need it or no 
improvement was seen 2 3 
Worry over side effects 3 1 
Didn't know purpose the drug 4 5 
Taking too many drugs already 5 2 
Fears of becoming dependent 6 6 
Forgot to get it filled 7 7 
Disagreed with the physician's 
assessment of the problem 8 4 
* N = 112 Pharmacists 
b N = 103 ESCGs 
Table 23. Correlation Matrix of Individual Importance Ratings of ESCG's Drag Intonation leeds 
with Pooled iesponses of Pharmacists and ESCGs* 
0.267 C 
0.406 0.377 D 
0.376 6.346 0.573 1 
0.366 0.493 0.534 0.6 
0.272 6.353 6.402 0.4 
0.266 0.346 0.157 0.2 
0.216 6.379 0.294 6.3 
0.241 0.316 0.399 0.4 
0.253 6.321 6.457 6.5 
0.339 0.367 0.477 0.5 
0.360 6.305 0.445 0.5 
0.196 0.232 0.235 0.4 
0.272 6.356 6.450 0.4 
0.254 0.331 0.366 0.5 
0.239 6.345 6.425 0.5 
0.316 0.226 0.275 0.3 
0.196 6.190 6.250 0.3 

















































































































Table 24. Varimax Rotated Factor Matrix for 19 Types of Perceived 
ESCG's Drug Information Needs Using Pooled Samples of 










K 0.837 0.809 
L 0.785 0.778 
J 0.741 0.653 
M 0.716 0.657 
O 0.674 0.679 
N 0.619 0.619 
Q 0.616 0.608 
T 0.857 0.783 
S 0.768 0.671 
U 0.742 0.730 
P 0.532 0.540 
D 0.748 0.682 
B 0.683 0.515 
E 0.625 0.657 
F 0.611 0.653 
H 0.839 0.766 
I 0.656 0.621 
G 0.552 0.549 
C 0.491 0.503 
Alpha 0.915 0.822 0.776 0.717 
Eigenvalue 8.594 1.572 1.227 1.081 12.47 
% Variance 45.2% 8.3% 6.5% 5.7% 65.7% 
* N = 217 (pooled data from 113 pharmacists, 104 ESCG) 
Items are from the individual types of drug information 
(items a and r excluded) 
Table 25. Factor Constructs Grouped by ESCGs Types of Drug Information 
Needs Using Pooled Samples of ESCGs and Pharmacists 
FACTOR 1: Side Effect Information ESCG- RPh*3 
k. How to recognize a possible side effect k. k. 
1. What exactly to do about a side effect 1. 1. 
j. Common side effects that may occur j. j. 
m. Ways to reduce a possible side effect m. m. 
0. Side effects from too much medication 0. 0. 
n. Side effects that needs to be reported n. -
q. What to do if a dose is missed - q. 
FACTOR 2; Interaction Information ESCG REil 
t. Over-the-counter medications to avoid t. t. 
s. Any problems/interactions with a new 
drug and other drugs currently used s. s. 
u. Other food/beverages/drugs to avoid u. u. 
p. Risks of not giving the medication p. p. 
n. 
FACTOR 3: Para-Professional Information ESCG &Ph 
d. How the medication works in the body d. d. 
b. Purpose of the medication - b. 
e. How to know if the drug is having 
the desired effects - e. 
f. When to expect to observe results f. f. 
c. 
FACTOR 4: Administrative Information 
h. Quantity to give at each time 
i. Should the medication be given with 
food or on an empty stomach 
g. Exact times of day to give the drug 







• N = 104 ESCGs 
* N = 113 RPh (pharmacist) 
•= N = 217 (pooled data from 113 pharmacists, 104 ESCGs) 





























Figure 5. Path Diagram of Significant Correlations of Indicators with the 
Four Extracted Factors* 
Pharmacist should 
tell the ESCGs 
about medications 
ESCGs have enough 
information about 
PTC drugs 


























* N = 113, scale was measured from 1 (strongly agree) to 5 (strongly disagree). 
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9. a. It your spouse currently taking any prescription Medications? 
No (0) Yes (1) If yes. bow aaay? 
b. Any over-the-counter aedlcatlons (aspirin, antacids, laxatives, analgesics, etc.) 
No (0) Yes (1) If yes. how aany? 
10. a. Are you currently taking any prescription aedlcatlons? 
No (0) Yes (1) If yes. how aany? 
b. Any over-1be-counter aedlcatlons (aspirin, antacids, laxatives, analgesics, etc.) 
No (0) Yes (1) If yaa, bow aany? 
11. Do you or your spouse currently take any of the following aedicatlons: 
0 . No 
1 - Yes. you only 
2 - Yes. spouse only 
3 - Yes. both 
a. Xanax. Librium, Tranxene. Valiua. Ativan. Serax, Centrax. Buspar 
b. Dalmane. Halcion. Restoril. Noctec, Placidyl. Seconal 
c. Elavil (Amitriptyllne), Norpramin. Adapin. Sinequan. Tofranil. Ludiomil. 
Pamelor. Desyrel (Trazodone) 
d. Haldol. Thorazine. Mellaril. Navane. Moban. Stelazine 
e. Other aedication for anxiety, tension, sleeplessness, depression. 
agitation, nerves, etc. 
NOTE: If respondent'6 answer to question #9 (a or b) was "No" do not complete the 
the remainder of this instrument. 
12. How responsible is your spouse for taking his/her aedications? 
a. He/she i6 responsible for taking the correct dose at the correct time. (1) 
b. Not responsible or capable of taking medications without help. (2) 
Please explain: 
13. What is most problematic for you about giving your spouse his/her medication? 
14. What would make it easier for you to give your spouse his/her medication? 
15. Which of the following statements do you agree with aore? 
a. It is my responsibility to ask a physician, pharmacist, or other health 
care professional questions about aedications. (1) 
b. The physician, pharaacist. or other health care professional will tell me 
anything that I should know about aedications without ny having to ask. (2) 
16. What is your general knowledge about prescription aedications? 
a lot (1) average (2) almost none (3) 
a. Has your knowledge of prescription aedications increased since your spouse 
became ill? 
_ No (0) Yes (1) 
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17. What is your general knowledge about over-the-counter aedications? 
a l o t average (2) alaost none (3) 
a. Has your knowledge of over-the-counter aedications increased since your spouse became ill? 
No (0) Yes (1) 
16. Do you know aore about your spouse's aedications than your own? 
NO (0) Yes (1) Other (8): 
19. Many people decide not to take a drug prascrlbad by a physician, or thay atop taking 
it without letting the physician know. Bava you aver decided not to give your spouse 
a abdication that was prescribed by a physician? 
No (0) Yes (1) 
If yes. of the following reasons, check all that apply: 
I felt they didn't need it because I didn't see any iaproveaent. 
I was worried about the side effects that I was told or had heard about. 
I forgot to get it filled. 
I couldn't afford it at the tiae. 
I thought they were already taking too aany aedications. 
I was afraid they would becoae dependent on the drug. 
I disagreed with the physician's assessaent of the problem. 
I didn't know the purpose of the aedication. 
I thought that another type of aedication/ or health food product/ or 
vitaain would be better. (Circle one of the three choices.) 
I felt that I could control the problem without a medication. 
Other (pl<ase specify): 
20.1 aa going to read you a list of iteas that relate to inforaation about your spouse's 
aedications. please indicate the level of iaportance for each using the following scale 
1 - Extremely iaportant or essential to know--would like to ask the physician 
or pharaacist if not told. Very useful information to know. 
2 » Iaportant to know--would like to be told the information, but may or may 
not ask for it. Useful to know. 
3 • Either iaportant or not important to know--may or may not be useful to know. 
would not ask for it. May be useful to know. 
4 - Not important to know--would not be useful information to know. 
5 - Extremely uuimportant--would not at all want that type of information. 
a. The naae of the aedication. 1 2 3 
b. The purpose of the aedication. 1 2 3 
c. How long he/she will be taking the aedication. 1 2 3 
d. How the aedication works in the body. 1 2 3 
e. How to know if the drug is having the desired 
effects. 1 2 3 
f. When to expect to observe results of the drug. 1 2 3 
g. The exact tiaes of the day to give aedication. 1 2 3 
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20. Continued 
h. The quantity of aedication to give at each tine. 
i. Should the aedication be given with food or on 
an empty stomach. 
j. Common side effects of the drug that may occur. 
k. How to recognize a possible side effect of the 
drug in spouse. 
1. What exactly to do about a side effect if it 
does occur. 
a. Ways to reduce the possibility of side effects. 
n. Side effects that need to be reported to 
a physician. 
o. Side effects from too auch of the aedication. 
p. The risks of not giving the aedication at all. 
q. What to do if a dose is missed. 
r. The cost of the aedication. 
Any problems or interactions with a new 
aedication and other drugs currently used. 
Over-the-counter aedications to avoid while 
using drug. 
Other food, beverages, or drugs to avoid. 
Other: 
. It is generally recognized that aost people forget froa tiae to time to take their 
medication as directed. Does this every happen to you? 
No (0) Yes (1) 
1£ yes. how often does it happen? 
a. almost never (once a month) (l) 
h- once in awhile (2-3 tiaes a month) (2) 
c. sometimes (once a week) (3) 
d• frequently (2-3 times a week) (4) 
e. almost daily (daily) (5) 
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22. Do you find it difficult to keep track of the aedications you and your spouse take? 
No (0) Yes (1) 
If yes. how often does it happen? 
a. almost never (once a month) (l) 
b. once in awhile (2-3 times a month) (2) 
c. sometimes (once a week) (3) 
d. frequently (2-3 times a week) (4) 
e. almost daily (daily) (5) 
a. Do you have a specific systea for keeping track? 
No (0) Yes (1) 
b. what is it? 
Would you like to learn more about developing a system? 
No (0) Yes (1) 
23. With whom do you discuss aost of your questions or concerns about your medications? 
(Check only one response.) 
a. physician (1) 
b. pharmacist (2) 
c. relative, friend (3) 








B a n a c l s t Survey; Mrtlcattcre and t t e Elderly 
Wiat Is your age? 
Gender: Mai* (1) Fecal* (2) 
Hew many year* hav« you been licensed u a pharmacist? 
What is the highest degree you hove ocnpletad? (Check one) 
a) B.S. (1) d) Ph.D. (4) 
b) M.S. (2) •) Other 






Please indicate the runber of hours you work per week (hrs/wk) 
in each of the following practice area(s): 
a) Hospital Pharmacy (hrs/wk) 
b) Independent Pharmacy (hrs/wk) 
c) Chain Pharaacy (hrs/wk) 
d) Other (hrs/wk) 
e) Not alloyed as a phnrmv-ist. 
6. below are professional services offered by sane pharmacies. 
Which do you routinely (over 50 percent of the time) provide to 
your patrons/patients? (Check all that apply). 
a) Counsel patients verbally an the proper use of medications. 
b) Provide written drug information. 
c) Maintain patient medication profiles. 
d) Provide aids to enhance compliance. 
e) Counsel patients about over-the-counter medications. 
f) Other services (please specify). 
7. What percent of your patrens/patients are ever 65 years old? 
8. 
9. 
agree nor disagree 
4 » disagree 
5 « strongly disagree 
a) It is the elderly spouse caregiver's responsibility to ask 
their physician or pharmacist questions about medications. 
b) The physician will tell the caregiver everything about 
medications without the caregiver having to ask. 
c) The pharmacist should tell the caregiver everything about 
their medication without the caregiver first inquiring. 
d) The number of prescriptions or physician's orders you fill 
a day interferes with your ability to counsel patients. 
e) Elderly caregiver's already have enough information about 
their prescription medications. 
f) Elderly caregiver's already have enough general knowledge 
about their over-the-counter medications. 
Do you or your aqployer provide ocnsulting servioes to oamunity 
nursing hones? No (0) Yes (1) 
Indicate your level of agreement of the following statements using the scale: 
1 - Strongly agree 3 » neither agree 
10. Have you ever provided, or do you currently provide care for a frail or 
disabled elder? No (0) Yes (1) 
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11. If you could provide pharmaceutical service* to primarily on* age group, 
which do you prefer? Please rank (i.e. 1, 2, 3, 4 4) the following in 
order of: 1 » most preferable E 4 • least preferable. 
0-17 years 18-34 years 35-64 years 65 and over 
12. Please circle True (T) or False (F) for the following statements: 
T F a. About 3 percent more of the aged have inoanes below the 
official poverty level ccspered to the rest of the population. 
T F b. All five senses decline in old age. 
T F c. About 80 percent of the aged are healthy enough to carry cut 
normal activities. 
T F d. Elderly take longer to learn sanething new. 
T F e. Lung vital capacity declines with age. 
T F f. Most medical practitioners tend to give low priority to the aged. 
T F g. Medicare pays over half of the ltwrilnal expenses of the aged. 
T F h. Older people have more acute (short-term) iniywew than 
persons under age 65. 
13. Belcw are listed a series of polar adjectives. Please circle the number 











in your judgement, 
friendly 

























14. Many people decide not to take a drug prescribed by a physician. 
Do caregivers ever decide not to give their spouse a prescribed drug? 
No (0) 
Yes (1) 
If yes, check three reasons from the following list: 
a) They didn't need it, no imu.dvmiihiit was seen. 
b) Worry over side effects they had heard about. 
c) They forgot to get it filled. 
d) They oouldn't afford it at the tine. 
e) Already talcing too many medications. 
f) Fears of beccming dependent on the drug. 
g) They disagreed with the physician's assessment of the problan. 
h) They didn't know the purpose of the medication. 





































15. Listed below are typee of drug information that Bay be provided to an 
elderly spouse caregiver about thalr •pause'• Dedications. In your 
opinion which types of information are the nost iaportant for you to 
provide the caregiver. Circle the rusher that indicates the level of 
ispartance using the following scale: 
1 » Extremely iaportant 
2 " Iaportant 
























The name of the Dedication. 
The purpose of the Dedication. 
How long will they be talcing the drug. 
How the Dedication works in the body. 
How to know if the drug is having 
the desired effects. 
Hhen to expect to observe results. 
The exact times of day to give the drug. 
The quantity to give at each time. 
Should the Dedication be given with food 
or on an eapty stomach. 
O.iiiuii side effects that Day occur. 
How to recognize a possible side effect. 
Yfrat exactly to do about a side effect. 
Ways to reduce a possible side effect. 
Side effects that need to be reported. 
Side effects from too auch medication. 
The risks of not giving the Dedication. 
What to do if a dose is missed. 
The co6t of the Dedication. 
Any problems or interactions with a new 
drug and other drugs currently used. 
Over-the-counter Dedications to avoid. 















































Is the type of drug information needed by an elder caring for their 
ill spouse different (i.e. greater than or of a different type) than 
your other patrons/patients? 
No (0) Yes (1) 
If yes, use the types of drug information listed in question I 15 
and circle the corresponding letter(s) (a,b,c...) that a caregiver 
needs to know: 




4 - Not iaportant 
5 - Extremely uniaportant 
























THANK YOU PCR YOUR TIME IN OCMPLEITNG THIS SURVEY. 
If you would like a copy of the results indicate your: 
Name: Address: 
City/State:. Zip Code:. 
APPENDIX C: 
INSTRUMENTS USED BY THE 
CAREGIVER'S SUPPORT PROJECT 
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1. ^I1"''*'' DBHOOBAPHICS COD 
Education: 
Occupation (prior): 
i m Ethnicity: 




a. Main Diagnosis: 
t. What is tha percent chance that your apousa vill ba institutionalized or placed in a nursing horn* in tha next year? With 0% being absolutely not. 50% meaning possibly, and 100% meaning absolutely. 
Annual Gross Income 
0 - 5.000 par year (1) 20.001 - 25.000 par year (5) 
5.001 - 10.000 per yaar (2) 25.001 - 30.000 per year (6) 
10,001 - 15.000 per year (3) over 30,001 per year (7) 
15.001 - 20,000 per year (4) 
4. Number of children: 
5. Number of children giving emotional or financial support to parents: 
6. Religion (optional): 
LDS (1) Jewish (4) 
Protestant (2) Other (5) 
Catholic (3) 
7. Is this your first marriage? Yes No 
If no. bow many times have you bean married before? 
a. How long have you been married (currant spouse)? (In years) 
/ / 
9. Is this your spouse's first marriage? Yes No 
If no. hov many times has your spouse been married before? 
10 Gander: Male Female 
11. How many months of careqivina 
NOTE: Record from 
screening form 
12. a. Are all children from this marriage? Yas No 
b. Caregiver How many giva support? _ Cararacaivar How many give support? Both How many give support? ~ 
13. On a scale of 1 - 10. how would you rate your spouse's health? 
1 - excellent, 10 - poor 1 2 3 4 5 6 7 0 9 10 
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CAREGIVER'S RATING OF HEALTH STATUS (02) 
[NOTE: If Intake Interview, skip Items X and 2] 
1. Is your health: better (1); worse; (2) 
about the same (3) since your last interview? 
2a. Since the last interview, did you have to stay in bed because of health 
Not at all (1) 
Somewhat (2) 
Great deal (3) 
b. What conditions caused you to stay in bed? 
c. Did you have to see a doctor? 
No (0) 
Yes (1) (number of visits) 
d. Did you have to go to the hospital? 
No (0) 
Yes (1) (number of visits) 




Poor (4 ) 
4. Is your health: better (1); worse; 2) 
about the same (3) since one year ago? 
5. Do health problems make helping your spouse difficult? 
Not at all (1) 
Somewhat (2) 
Great deal (3) 
6. Do health problems stand in the way of doing the things you want to do? 
Not at all (1) 
Somewhat (2) 
Great deal (3) 
7. Do you have to take it easy, or cut out an activity because of health 
problems? 
Not at all (1) 
Somewhat (2) 
Great deal (3) 
8. Since you began giving a great deal of care to your spouse, you may have 
experienced change in many areas. I will read seven statements to you. 
answer each with the following scale: 
1 • A lot more (better) 4 > A little less (worse) 
2 • A little more (better) 5 - A lot less (worse) 
3 = The same 8 • Don't know 
01. Amount of time you have to yourself. 
02. Amount of privacy you have. 
03. Amount of personal freedom you have. 
04. Amount of energy you have. 
05. Amount of time you 6pend in recreational and/or social activities. 
06. Amount of vacation activities and trips you take. 
07. Your relationships with other family members. 
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PATIENT BEHAVIORAL EVALUATION (04) 
Please tell me how often in the past month you have performed each of the following 
tasks for your spouse. Then rate the level of dependency on each task using the 
following scale. 
Column A Scale 
0 - Never, or record number 
of times In past month 
(i.e., dally . 30). 
(e.g.. Ask, "How many 
times have you 
in the past month?" 
Column B Scale 
1 • Dependent (cannot complete 
task without assistance) 
2 • Needs Assistance 
3 • Needs Assistance/ 
Supervision 
4 • Needs supervision 
5 - Independent (completes tasks 
without assistance) 
(e.g.. Ask, "Using the scale, 
how much assistance does your 






!-:nd number in phone book 
Cial telephone number 
appropriately 
vtite legible signature 
•«ir:.t*/type simple message 
or.e sentence 
Seai newspaper headlines 
Y3NEY HANDLING SKILLS 
Hindle/sort bills 
u3nd'.e/sort coins 
I sunt correctly a given 
a x c u n t 
.-'.ar. a simple budget 
n:i;e a check appropriately 
3. FOOD PREPARATION SKILLS 
Plan appropriate meals for 
self 
Prepare cold meal (i.e.. sandwich) 
Prepare hot meal 
(i.e., macaroni and cheesa) 
Use simple recipe 
(i.e.. macaroni and cheese) 
Clean-up kitchen area 
4. HOME MAINTENANCE SKILLS 
Make bed 
Clean floor with broom 
Sort laundry appropriately 
Use washer and dryer 
appropriately 
frequency Dependency 




Wheel chair mobility 
Bed transfer 
Toilet transfer 














Plate to hand to mouth 
INDEPENDENT LIVING SKILLS 
Use phone 
Legal signature 
Write/type simple message 
Manipulate money 
Plan simple budget 
Plan meals 
Prepare a cold meal 
Prepare a hot meal 
Home maintenance activities 
Plan a daily schedule 
Responsible for medication 
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CONFIDENCE OF UNDERSTANDING (OS) 
[CIRCLE THE NUMBER WHICH MOST CLOSELY CORRESPONDS TO THE RESPONSE.] 
1 - Not At All Confident 
2 - Less Than Average Confidence 
3 » Average Confidence 
4 - More Than Average Confidence 
5 - Very Confident 
Taking care of an ill spouse requires understanding of a large number of issues. For the list of issues I will read, please indicate how confident you are that you understand each issue well enough to adequately take care of your loved one. 
1. How to handle ray own stresses. 
2. Common medical problems in elders. 
3. Common mental health problems 
in elders. 
4. Financial issues related to the elder. 
5. Legal issues related to the elder. 
6. Available medical services. 
7. Available mental health services. 
8. How to make decisions about long-term 
care, like nursing homes. 
9. Special nutritional needs of elders. 
10. How to appropriately work with the 
elder's health care providers. 
11. How to appropriately involve 
neighbors, church members, and others 
in caretaking of my elderly loved one. 
12. Special medication considerations. 
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CAREGIVER STRAIN INDEX (06) 
I am going to read a list of things which other people have found to be 
difficult in giving care to a spouse with a serious illnes6. Would you 
tell me "YES" or "NO" if any of these apply to you? (GIVE EXAMPLES. CHECK 
APPROPRIATE RESPONSE COLUMN).) 
Yes 
0 1 . 








Sleep is disturbed (e.g.. because 
out of bed or wanders around at night). 
is in and 
12 . 
13 . 
It is inconvenient (e.g., because helping takes 
so much time). 
It is a physical strain (e.g., because of 
lifting in and out of a chair: effort or 
concentration is required). 
It is confining (e.g., helping restricts free 
time or cannot go visiting). 
There have been family adjustments (e.g., 
because helping has disrupted routine; there has 
been no pr ivacy) . 
There have been changes in personal plans (e.g., 
had to turn down a job; could not go on vacation). 
There have been other demands on my time 
(e.g.. from other family members). 
There have been emotional adjustments 
(e.g., from other family members). 
Some behavior is upsetting (e.g., because of 
incontinence; has trouble remembering things; 
or accuses people of taking things). 
It is upsetting to find has changed so much 
from his/her former self (e.g.. he/she is a 
different person than he/she used to be). 
There have been work adjustments (e.g., 
because of having to take time off). 
It is a financial strain. 
Feeling completely overwhelmed (e.g.. 
because of worry about ; concerns 
about how you will manage). 
TOTAL SCORE (count YES responses) 
No 
NCTE: From Validation of a Caregiver Strain Index by B.C. Robinson. 
1983. Journal of Gerontology. 38., 344-348. Copyright 1983 by Journal 
zi Jerontology. Reprinted by permission. 
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MRP EH SCALE (07) 
IHSTKUCTIONS: I would like to ask you about soma feeling* that you may have fine* giving eare 
to your spouse. On a scale from on* (strongly agree), to five (strongly disagree), 
rat* your l*vel of agreement on **ch of tha statement*. 
3 - Neither Agr** nor Disagree 
01. I feel resentful of oth*r r*latlv*s who could, but who do not do things for my spouse. 
02. 1 feel that my spouse makes requests which I p*rc*iv* to b* ov*r and above what 
s/h« needs. 
03. Because of my involvement with my spouse, I don't hav* anough tin* for myself. 
0*. I feel stressed between trying to give to my spouse as well as to other family 
responsibilities. Job, «tc. 
05. I feel embarrassed over my spouse's b«havior. 
06. I feel guilty about my Interactions with my spouse. 
07. I feel that I don't do as much for my spouse as I could or should. 
08. I feel angry about my interactions with my spouse. 
09. I feel that in the past, I haven't don* as such for my spouse as I could or 
should have. 
10. 1 feel nervous or depressed about my interactions with my spous*. 
11. I feel that my spouse currently affect* my relationships with other family members 
and friends in a negative w»y. 
12. I feel resentful about my interactions with my spous*. 
13. I am afraid of what the futur* holds for my spous*. 
It. I feel pleased about my interactions with my spouse. 
15. It's painful to watch my spous* ag*. 
16. I feel useful in my interactions with my spous*. 
17. I feel my spouse is dependent. 
18. I feel strained in my interactions with my spouse. 
19. I feel that my health has suffered bacausa of my involvament with my 
spouse. 
20. I feel that I am contributing to tha wall-baing of my spous*. 
21. I feel that th* present altuation with my spous* doesn't allow me as much privacy 
as I'd lik*. 
22. I feel th*t my social Ufa has suffered bacaus* of my involvement with my spous*. 
23. I wish that my spous* and I had a batter relationship. 
2*. I feel that my spous* doasn't appreciate what I do for him/her as much as I would lik*. 
25. 1 f*el uncomfortable whan I hav* friands over. 
26. I feel that my spous* trias to manipulate m. 
27. I feel that my spouse seams to expect ma to take care of him/her as if I were the 
only one s/h* could depend on. 
28. I f**l that I don't hav* anough non*y to support my spous* in addition to th* rest 
of our expenses. 
29. I feel that I would like to be able to provide mora monay to support my 
spouse than I am able to now. 
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profile or mood m T P (rows) (09) 
INSTRUCTIONS: I will read a list of words that dascrlba feelings paopla hav*. Plaasa Indicate 
MOW YOU HAVI ttU rtlLIHC DUR1NC THE PAST WEE* IBCLUDIBC TODAY, using tha following answers.. 
1 • Not at all 4 - Quite • bit 
2 - A little S - Extraaaly 
1 • Moderately 8 - Don't know 
01. Friendly 1 2 3 4 5 8 33. Resentful . . . . 1 2 3 4 5 8 
02. Tense 1 2 3 4 5 8 34. Nervous . . . . 1 2 3 4 5 8 
03. Angry 1 2 3 4 5 8 35. Lonely . . . . 1 2 3 4 5 8 
04. Worn Out 1 2 3 4 5 8 34. Miserable . . . . 1 2 3 4 5 8 
05. Unhappy 1 2 3 4 5 8 37. Muddled . . . . 1 2 3 4 5 8 
04. Clear-headed. . 1 2 3 4 5 8 38. Cheerful . . . . 1 2 3 4 5 8 
07. Lively 1 2 3 4 5 8 39. Bitter . . . . 1 2 3 4 5 8 
08. Confused 1 2 3 4 5 8 40. Exhausted . . . . 1 2 3 4 5 8 
09. Sorry for things dona . 1 2 3 4 5 41. Anxious . . . . 1 2 3 4 5 8 
10. Shaky 1 2 3 4 5 8 42. Beady to fight 1 2 3 4 5 8 
11. Listless 1 2 3 4 5 8 43. Cood naturad . . . 1 2 3 4 5 8 
12. Peeved 1 2 3 4 5 8 44. Cloony . . . . 1 2 3 4 5 8 
13. Considerate . . 1 2 3 4 5 8 45. Desperate . . . . 1 2 3 4 5 8 
14. Sad 1 2 3 4 5 8 46. Sluggish . . . . 1 2 3 4 5 8 
15. Active 1 2 3 4 5 8 47. Rebellious. . . . 1 2 3 4 5 8 
16. On edge 1 2 3 4 5 8 48. Helpless . . . . 1 2 3 4 5 8 
17. Crouchy 1 2 3 4 5 8 49. Uaary . . . . 1 2 3 4 5 8 
18. Blue 1 2 3 4 5 8 50. Bewildered. . . . 1 2 3 4 5 8 
19. Energetic 1 2 3 4 5 8 51. Alert . . . . 1 2 3 4 5 8 
20. Panicky 1 2 3 4 5 8 52. Deceived . . . . 1 2 3 4 5 8 
21. Hopeless 1 2 3 4 5 8 53. Furious . . . . 1 2 3 4 5 8 
22. Relaxed 1 2 3 4 5 8 54. Efficient . . . . 1 2 3 4 5 8 
33. Unworthy 1 2 3 4 5 8 55. Trusting . . . . 1 2 3 4 5 8 
2*. Spiteful . . 1 2 3 4 5 8 56. Full of pep . . . 1 2 3 4 5 8 
:5 Sympathetic . . 1 2 3 4 5 8 57. Bad-taapared . . . 1 2 3 4 5 8 
26. Uneasy 1 2 3 4 5 8 58. Worthies 1 2 3 4 5 8 
27. Restless 1 2 3 4 5 8 59. Forgetful . . . . 1 2 3 4 5 8 
23. Unable to concentrate 1 2 3 4 5 8 60. Carafr** . . . . 1 2 3 4 5 8 
29. Fatigued 1 2 3 4 5 8 61. Terrified . . . . 1 2 3 4 5 8 
30. Helpful 1 2 3 4 5 8 62. Cuilty . . . . 1 2 3 4 5 8 
31. Annoyed 1 2 3 4 5 8 63. Vigorous . . . . 1 2 3 4 5 8 
32. Discouraged . . . . 1 2 3 4 5 8 64. Uncertain about things 1 2 3 4 5 8 
65. Bushed 1 2 3 4 5 8 
PONS (021) COPYRIGHT ©1971 Ed ITS/EDUCATIONAL AND INDUSTRIAL TESTING SERVICE, SAB DIEGO, CA 92107 
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